Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


Articles published in Hepatology

Retrieve available abstracts of 445 articles:
HTML format
Text format



Single Articles


    July 2017

  1. Hepatology Highlights.
    Hepatology. 2017;66:1-3.
    PubMed     Text format    


    June 2017
  2. HENRIET E, Hammoud AA, Dupuy JW, Dartigues B, et al
    Argininosuccinate synthase 1 (ASS1): A marker of unclassified hepatocellular adenoma and high bleeding risk.
    Hepatology. 2017 Jun 23. doi: 10.1002/hep.29336.
    PubMed     Text format     Abstract available


  3. TSAI CL, Liu WL, Hsu FM, Yang PS, et al
    Targeting Histone deacetylase 4/Ubc9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells.
    Hepatology. 2017 Jun 23. doi: 10.1002/hep.29328.
    PubMed     Text format     Abstract available


  4. LIU Y, Zhang Y, Wang S, Dong QZ, et al
    Prospero-related homeobox 1 drives angiogenesis of hepatocellular carcinoma through selectively activating IL-8 expression.
    Hepatology. 2017 Jun 23. doi: 10.1002/hep.29337.
    PubMed     Text format     Abstract available


  5. DAWSON PA
    Hepatic bile acid uptake in humans and mice: Multiple pathways and expanding potential role for gut-liver signaling.
    Hepatology. 2017 Jun 23. doi: 10.1002/hep.29325.
    PubMed     Text format    


  6. ZHANG C, Huang J, An W
    Hepatic stimulator substance resists hepatic ischemia-reperfusion injury by regulating Drp1 translocation and activation.
    Hepatology. 2017 Jun 23. doi: 10.1002/hep.29326.
    PubMed     Text format     Abstract available


  7. YIP LY, Aw CC, Lee SH, Hong YS, et al
    The Liver-Gut Microbiota Axis Modulates Hepatotoxicity of Tacrine in the Rat.
    Hepatology. 2017 Jun 23. doi: 10.1002/hep.29327.
    PubMed     Text format     Abstract available


  8. KIM DS, Ryu JW, Son MY, Oh JH, et al
    A Liver-specific Gene Expression Panel Predicts the Differentiation Status of in vitro Hepatocyte Models.
    Hepatology. 2017 Jun 22. doi: 10.1002/hep.29324.
    PubMed     Text format     Abstract available


  9. PAPATHEODORIDIS GV, Idilman R, Dalekos GN, Buti M, et al
    The risk of hepatocellular carcinoma is decreasing after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B.
    Hepatology. 2017 Jun 16. doi: 10.1002/hep.29320.
    PubMed     Text format     Abstract available


  10. CHIDA T, Ito M, Nakashima K, Kanegae Y, et al
    Critical role of CREBH-mediated induction of TGF-beta2 by HCV infection in fibrogenic responses in hepatic stellate cells.
    Hepatology. 2017 Jun 16. doi: 10.1002/hep.29319.
    PubMed     Text format     Abstract available


  11. LEE M, Chung GE, Lee JH, Oh S, et al
    Antiplatelet therapy and the risk of hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment.
    Hepatology. 2017 Jun 15. doi: 10.1002/hep.29318.
    PubMed     Text format     Abstract available


  12. GAO Y, Feng J, Yang G, Zhang S, et al
    HBx-elevated MSL2 Modulates HBV cccDNA through Inducing Degradation of APOBEC3B to Enhance Hepatocarcinogenesis.
    Hepatology. 2017 Jun 13. doi: 10.1002/hep.29316.
    PubMed     Text format     Abstract available


  13. TAYLOR EJ, Jones RL, Guthrie JA, Rowe IA, et al
    Modelling the benefits and harms of surveillance for hepatocellular carcinoma: information to support informed choices.
    Hepatology. 2017 Jun 12. doi: 10.1002/hep.29315.
    PubMed     Text format     Abstract available


  14. JIANG L, Yan Q, Fang S, Liu M, et al
    Calcium binding protein 39 promotes hepatocellular carcinoma growth and metastasis by activating ERK signaling pathway.
    Hepatology. 2017 Jun 12. doi: 10.1002/hep.29312.
    PubMed     Text format     Abstract available


  15. BALWANI M, Wang B, Anderson KE, Bloomer JR, et al
    Acute Hepatic Porphyrias: Recommendations for Evaluation and Long Term Management.
    Hepatology. 2017 Jun 12. doi: 10.1002/hep.29313.
    PubMed     Text format     Abstract available


  16. ZHENG C, Zeng H, Lin H, Wang J, et al
    Serum microcystins level positively linked with risk of hepatocellular carcinoma: a case-control study in Southwest China.
    Hepatology. 2017 Jun 9. doi: 10.1002/hep.29310.
    PubMed     Text format     Abstract available


  17. NG CKY, Piscuoglio S, Terracciano LM
    Molecular classification of hepatocellular carcinoma: The view from metabolic zonation.
    Hepatology. 2017 Jun 9. doi: 10.1002/hep.29311.
    PubMed     Text format    


  18. AKINROTIMI O, Riessen R, VanDuyne P, Park JE, et al
    Shp deletion prevents hepatic steatosis and when combined with Fxr loss protects against type 2 diabetes.
    Hepatology. 2017 Jun 6. doi: 10.1002/hep.29305.
    PubMed     Text format     Abstract available


  19. BAJAJ JS, Kassam Z, Fagan A, Gavis EA, et al
    Fecal Microbiota Transplant from a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial.
    Hepatology. 2017 Jun 6. doi: 10.1002/hep.29306.
    PubMed     Text format     Abstract available


  20. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2017;65:1783-1784.
    PubMed     Text format    


    May 2017
  21. MARKWARDT D, Holdt L, Steib C, Benesic A, et al
    Plasma Cystatin C is a predictor of renal dysfunction, ACLF and mortality in patients with acutely decompensated liver cirrhosis.
    Hepatology. 2017 May 25. doi: 10.1002/hep.29290.
    PubMed     Text format     Abstract available


  22. WANG Z, Han J, Zhang H, Wu MC, et al
    Emphasis on Harms of Hepatocellular Carcinoma Surveillance: Just Pretending Innocent After Taking Advantages?
    Hepatology. 2017 May 24. doi: 10.1002/hep.29288.
    PubMed     Text format    


  23. MASYUK TV, Masyuk AI, Lorenzo Pisarello M, Howard BN, et al
    TGR5 contributes to hepatic cystogenesis in rodents with polycystic liver diseases via cAMP/Galphas signaling.
    Hepatology. 2017 May 23. doi: 10.1002/hep.29284.
    PubMed     Text format     Abstract available


  24. TSOCHATZIS EA, Bosch J
    Statins in cirrhosis - ready for prime time.
    Hepatology. 2017 May 22. doi: 10.1002/hep.29277.
    PubMed     Text format    


  25. POSSO-OSORIO I, Mendez-Rayo T, Andres Jimenez C, Escobar D, et al
    Hepatic infiltration by silicone in a patient with asia syndrome.
    Hepatology. 2017 May 18. doi: 10.1002/hep.29274.
    PubMed     Text format    


  26. CHO CS, Lombard DB, Lee JH
    SIRT3 as a Regulator of Hepatic Autophagy.
    Hepatology. 2017 May 18. doi: 10.1002/hep.29271.
    PubMed     Text format    


  27. HAN D, Li J, Wang H, Su X, et al
    Circular RNA MTO1 acts as the sponge of miR-9 to suppress hepatocellular carcinoma progression.
    Hepatology. 2017 May 18. doi: 10.1002/hep.29270.
    PubMed     Text format     Abstract available


  28. BUENDIA MA, Armengol C, Cairo S
    Molecular classification of hepatoblastoma and prognostic value of the HB 16-gene signature.
    Hepatology. 2017 May 16. doi: 10.1002/hep.29262.
    PubMed     Text format    


  29. SAFIRI S, Ayubi E
    Dual photon microscopy based quantitation of fibrosis-related parameters (q-FP) to model disease progression in steatohepatitis: Methodological issues.
    Hepatology. 2017 May 16. doi: 10.1002/hep.29261.
    PubMed     Text format    


  30. ZHANG QY, Zhao LP, Tian XX, Yan CH, et al
    The novel intracellular protein CREG inhibits hepatic steatosis, obesity and insulin resistance.
    Hepatology. 2017 May 15. doi: 10.1002/hep.29257.
    PubMed     Text format     Abstract available


  31. SLIJEPCEVIC D, Roscam Abbing RLP, Katafuchi T, Blank A, et al
    Hepatic uptake of conjugated bile acids is mediated by both NTCP and OATPs and modulated by intestinal sensing of plasma bile acid levels in mice.
    Hepatology. 2017 May 12. doi: 10.1002/hep.29251.
    PubMed     Text format     Abstract available


  32. DESERT R, Rohart F, Canal F, Sicard M, et al
    Human Hepatocellular Carcinomas with a Periportal Phenotype Have the Lowest Potential for Early Recurrence after Curative Resection.
    Hepatology. 2017 May 12. doi: 10.1002/hep.29254.
    PubMed     Text format     Abstract available


  33. ZHAO E, Ilyas G, Cingolani F, Choi JH, et al
    Pentamidine Blocks Hepatotoxic Injury in Mice.
    Hepatology. 2017 May 3. doi: 10.1002/hep.29244.
    PubMed     Text format     Abstract available


  34. O'HARA SP, LaRusso NF
    Cellular Senescence, Neuropeptides and Hepatic Fibrosis: Additional Insights into Increasing Complexity.
    Hepatology. 2017 May 2. doi: 10.1002/hep.29243.
    PubMed     Text format    


  35. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2017;65:1429-1431.
    PubMed     Text format    


  36. DULAI PS, Singh S, Patel J, Soni M, et al
    Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.
    Hepatology. 2017;65:1557-1565.
    PubMed     Text format     Abstract available


  37. PARK JK, Shao M, Kim MY, Baik SK, et al
    An endoplasmic reticulum protein, Nogo-B, facilitates alcoholic liver disease through regulation of kupffer cell polarization.
    Hepatology. 2017;65:1720-1734.
    PubMed     Text format     Abstract available


  38. XIANG D, Cheng Z, Liu H, Wang X, et al
    Shp2 promotes liver cancer stem cell expansion by augmenting beta-catenin signaling and predicts chemotherapeutic response of patients.
    Hepatology. 2017;65:1566-1580.
    PubMed     Text format     Abstract available


  39. O'HARE EA, Yang R, Yerges-Armstrong LM, Sreenivasan U, et al
    TM6SF2 rs58542926 impacts lipid processing in liver and small intestine.
    Hepatology. 2017;65:1526-1542.
    PubMed     Text format     Abstract available


  40. HOU G, Chen L, Liu G, Li L, et al
    Aldehyde dehydrogenase-2 (ALDH2) opposes hepatocellular carcinoma progression by regulating AMP-activated protein kinase signaling in mice.
    Hepatology. 2017;65:1628-1644.
    PubMed     Text format     Abstract available


  41. RAVA M, D'Andrea A, Doni M, Kress TR, et al
    Mutual epithelium-macrophage dependency in liver carcinogenesis mediated by ST18.
    Hepatology. 2017;65:1708-1719.
    PubMed     Text format     Abstract available


    April 2017
  42. WON JK, Yu SJ, Hwang CY, Cho SH, et al
    Protein disulfide isomerase inhibition synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma.
    Hepatology. 2017 Apr 25. doi: 10.1002/hep.29237.
    PubMed     Text format     Abstract available


  43. ZHENG X, Xu F, Liang H, Cao H, et al
    SIRT1/HSF1/HSPs Pathway is Essential for Exenatide-alleviated Lipid-induced Hepatic Endoplasmic Reticulum Stress.
    Hepatology. 2017 Apr 25. doi: 10.1002/hep.29238.
    PubMed     Text format     Abstract available


  44. SRIVASTAVA J, Robertson CL, Ebeid K, Dozmorov M, et al
    A Novel Role of Astrocyte Elevated Gene-1 (AEG-1) in Regulating Non-alcoholic Steatohepatitis (NASH).
    Hepatology. 2017 Apr 24. doi: 10.1002/hep.29230.
    PubMed     Text format     Abstract available


  45. LI S, Dou X, Ning H, Song Q, et al
    SIRT3 Acts As a Negative Regulator of Autophagy Dictating Hepatocyte Susceptibility to Lipotoxicity.
    Hepatology. 2017 Apr 24. doi: 10.1002/hep.29229.
    PubMed     Text format     Abstract available


  46. KOKUDO T, Hasegawa K, Matsuyama Y, Takayama T, et al
    Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: a Japanese nationwide survey.
    Hepatology. 2017 Apr 24. doi: 10.1002/hep.29225.
    PubMed     Text format     Abstract available


  47. PEMBROKE T, Sebastiani G
    Hepatic steatosis, hepatitis C and human immunodeficiency viruses: A complex interplay.
    Hepatology. 2017 Apr 19. doi: 10.1002/hep.29218.
    PubMed     Text format    


  48. KUO F, Park J, Chen A
    Coil Assisted Retrograde Transvenous Obliteration and Partial Splenic Artery Embolization for Hepatic Encephalopathy.
    Hepatology. 2017 Apr 13. doi: 10.1002/hep.29212.
    PubMed     Text format    


  49. LI Y, Song Y, Zhao M, Guo Y, et al
    A Novel Role for CRTC2 in Hepatic Cholesterol Synthesis via SREBP-2.
    Hepatology. 2017 Apr 10. doi: 10.1002/hep.29206.
    PubMed     Text format     Abstract available


  50. ONO A, Goossens N, Finn RS, Schmidt WN, et al
    Persisting risk of hepatocellular carcinoma after HCV cure monitored by a liver transcriptome signature.
    Hepatology. 2017 Apr 8. doi: 10.1002/hep.29203.
    PubMed     Text format    


  51. ZHANG H, Li ZL, Xing H, Wu MC, et al
    Hepatocellular Carcinoma Surveillance: Sometimes Just Specialists' Incidental Behavior?
    Hepatology. 2017 Apr 7. doi: 10.1002/hep.29200.
    PubMed     Text format    


  52. KIM KH, Choi S, Zhou Y, Kim EY, et al
    Hepatic FXR/SHP Axis Modulates Systemic Glucose and Fatty Acid Homeostasis in Aged Mice.
    Hepatology. 2017 Apr 5. doi: 10.1002/hep.29199.
    PubMed     Text format     Abstract available


  53. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2017;65:1081-1083.
    PubMed     Text format    


    March 2017
  54. TOHME S, Yazdani HO, Liu Y, Loughran P, et al
    Hypoxia mediates mitochondrial biogenesis in hepatocellular carcinoma to promote tumor growth via HMGB1 and TLR9 interaction.
    Hepatology. 2017 Mar 30. doi: 10.1002/hep.29184.
    PubMed     Text format     Abstract available


  55. LIU P, Ge M, Hu J, Li X, et al
    A functional mTORC1 signaling is indispensable for c-Myc driven hepatocarcinogenesis.
    Hepatology. 2017 Mar 30. doi: 10.1002/hep.29183.
    PubMed     Text format     Abstract available


  56. SORIA A, Fabbiani M, Lapadula G, Gori A, et al
    Unexpected viral relapses in HCV-infected patients diagnosed with hepatocellular carcinoma during treatment with DAAs.
    Hepatology. 2017 Mar 30. doi: 10.1002/hep.29181.
    PubMed     Text format    


  57. SORIANO G, Bajaj JS
    Grading the range of hepatic encephalopathy from overt to covert: Animals to the Rescue!
    Hepatology. 2017 Mar 30. doi: 10.1002/hep.29186.
    PubMed     Text format    


  58. CHANG FM, Wang YP, Lang HC, Tsai CF, et al
    Statins decrease the risk of decompensation in HBV- and HCV-related cirrhosis: A population-based study.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29172.
    PubMed     Text format     Abstract available


  59. SASAKI R, Devhare PB, Steele R, Ray R, et al
    Hepatitis C virus induced CCL5 secretion from macrophages activates hepatic stellate cells.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29170.
    PubMed     Text format     Abstract available


  60. NAHON P, Seror O, Durand-Zaleski I
    Reply to: <<Screening for Hepatocellular carcinoma: A drug safety issue>>.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29174.
    PubMed     Text format    


  61. BRAILLON A
    Screening for hepatocellular carcinoma: A drug safety issue.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29173.
    PubMed     Text format    


  62. DE MATTOS AZ, Miozzo SA, Tovo CV, de Mattos AA, et al
    Risks of proton pump inhibitors for cirrhotic patients - the controversy remains.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29132.
    PubMed     Text format    


  63. MOLLER S, Hove JD
    Assessment of systolic function in the evaluation of patients with cirrhosis.
    Hepatology. 2017 Mar 20. doi: 10.1002/hep.29163.
    PubMed     Text format    


  64. SINCLAIR M, Schelleman A, Sandhu D, Angus PW, et al
    Regression of hepatocellular adenomas and systemic inflammatory syndrome after cessation of estrogen therapy.
    Hepatology. 2017 Mar 13. doi: 10.1002/hep.29151.
    PubMed     Text format     Abstract available


  65. YANG Y, Zhou Y, Hou J, Bai C, et al
    Hepatic IFIT3 predicts interferon-alpha therapeutic response in patients of hepatocellular carcinoma.
    Hepatology. 2017 Mar 13. doi: 10.1002/hep.29156.
    PubMed     Text format     Abstract available


  66. HE Y, Feng D, Li M, Gao Y, et al
    Hepatic mtDNA-TLR9-microRNA-223 forms a negative feedback loop to limit neutrophil over-activation and acetaminophen hepatotoxicity.
    Hepatology. 2017 Mar 13. doi: 10.1002/hep.29153.
    PubMed     Text format     Abstract available


  67. FLORIMONTE L, Iavarone M, Castellani M, Longo M, et al
    Uncommon extrahepatic metastases from hepatocellular carcinoma.
    Hepatology. 2017 Mar 10. doi: 10.1002/hep.29147.
    PubMed     Text format    


  68. WANG L, Zhang W, Ge CH, Yin RH, et al
    TLR5 signaling restrains T/NKT cell activation and protects against concanavalin A-induced hepatic injury.
    Hepatology. 2017 Mar 8. doi: 10.1002/hep.29140.
    PubMed     Text format     Abstract available


  69. CAMPAGNA F, Montagnese S, Ridola L, Senzolo M, et al
    The animal naming test: An easy tool for the assessment of hepatic encephalopathy.
    Hepatology. 2017 Mar 8. doi: 10.1002/hep.29146.
    PubMed     Text format     Abstract available


  70. WAN Y, Meng F, Wu N, Zhou T, et al
    Substance P increases liver fibrosis by differential changes in senescence of cholangiocytes and hepatic stellate cells.
    Hepatology. 2017 Mar 3. doi: 10.1002/hep.29138.
    PubMed     Text format     Abstract available


  71. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2017;65:761-762.
    PubMed     Text format    


    February 2017
  72. FAN Z, Li L, Li M, Zhang X, et al
    The histone methyltransferase Suv39h2 contributes to non-alcoholic steatohepatitis in mice.
    Hepatology. 2017 Feb 28. doi: 10.1002/hep.29127.
    PubMed     Text format     Abstract available


  73. YAN F, Wang Y, Zhang W, Chang M, et al
    Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection.
    Hepatology. 2017 Feb 25. doi: 10.1002/hep.29134.
    PubMed     Text format     Abstract available


  74. DAM G, Vilstrup H, Watson H, Jepsen P, et al
    Reply to letter from de Mattos and colleagues: Risks of proton pump inhibitors for cirrhotic patients - the controversy remains.
    Hepatology. 2017 Feb 21. doi: 10.1002/hep.29131.
    PubMed     Text format    


  75. WANG W, Xu MJ, Cai Y, Zhou Z, et al
    Inflammation is independent of steatosis in a murine model of steatohepatitis.
    Hepatology. 2017 Feb 21. doi: 10.1002/hep.29129.
    PubMed     Text format     Abstract available


  76. SABERI B, Dadabhai AS, Durand CM, Philosophe B, et al
    Challenges in Treatment of Hepatitis C among Patients with Hepatocellular Carcinoma.
    Hepatology. 2017 Feb 17. doi: 10.1002/hep.29126.
    PubMed     Text format    


  77. LI H, Zhou ZQ, Yang ZR, Tong DN, et al
    MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma.
    Hepatology. 2017 Feb 14. doi: 10.1002/hep.29116.
    PubMed     Text format     Abstract available


  78. LEMPP FA, Wiedtke E, Qu B, Roques P, et al
    Sodium taurocholate cotransporting polypeptide is the limiting host factor of Hepatitis B Virus infection in macaque and pig hepatocytes.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29112.
    PubMed     Text format     Abstract available


  79. BRUDEN DJ, McMahon BJ, Townshend-Bulson L, Gounder P, et al
    Risk of End Stage Liver Disease, Hepatocellular Carcinoma and Liver-Related Death By Fibrosis Stage in the Hepatitis C Alaska Cohort.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29115.
    PubMed     Text format     Abstract available


  80. WANG H, An P, Xie E, Wu Q, et al
    Characterization of Ferroptosis in Murine Models of Hemochromatosis.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29117.
    PubMed     Text format     Abstract available


  81. GOLDEN-MASON L, Rosen HR
    Galectin-9: Diverse Roles in Hepatic Immune Homeostasis and Inflammation.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29106.
    PubMed     Text format     Abstract available


  82. IWAKIRI Y
    Reply to the Letter to the Editor in regards to the commentary on "The lymphatic system: A new frontier in hepatology".
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29102.
    PubMed     Text format    


  83. YOTTI R, Ripoll C, Benito Y, Catalina MV, et al
    Left ventricular systolic function is associated to sympathetic nervous activity and markers of inflammation in cirrhosis.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29104.
    PubMed     Text format     Abstract available


  84. GOLDSWORTHY MA, Rowe IA
    Patient understanding of hepatocellular carcinoma surveillance.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29103.
    PubMed     Text format    


  85. KUMAR A, Davuluri G, deSilva RN, Engelen MP, et al
    Ammonia lowering reverses sarcopenia of cirrhosis by restoring skeletal muscle proteostasis.
    Hepatology. 2017 Feb 13. doi: 10.1002/hep.29107.
    PubMed     Text format    


  86. KRAWCZYK M, Rau M, Grunhage F, Schattenberg JM, et al
    The ABCB4 p.T175A variant as potential modulator of hepatic fibrosis in patients with chronic liver diseases: Looking beyond the cholestatic realm.
    Hepatology. 2017 Feb 8. doi: 10.1002/hep.29100.
    PubMed     Text format    


  87. CADIER B, Bulsei J, Nahon P, Seror O, et al
    Early detection and curative treatment of hepatocellular carcinoma: A cost-effectiveness analysis in France and in the United States.
    Hepatology. 2017 Feb 8. doi: 10.1002/hep.28961.
    PubMed     Text format     Abstract available


  88. LEE MW, Raman SS, Asvadi NH, Siripongsakun S, et al
    Radiofrequency Ablation of Hepatocellular Carcinoma as Bridge Therapy to Liver Transplantation: A Ten Year Intention-to-treat Analysis.
    Hepatology. 2017 Feb 7. doi: 10.1002/hep.29098.
    PubMed     Text format     Abstract available


  89. FERNANDEZ CARRILLO C, Lens S, Llop E, Pascasio JM, et al
    Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of MELD: Analysis of data from the Hepa-C registry.
    Hepatology. 2017 Feb 7. doi: 10.1002/hep.29097.
    PubMed     Text format     Abstract available


  90. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2017;65:399-400.
    PubMed     Text format    


    January 2017
  91. VILASECA M, Garcia-Caldero H, Lafoz E, Garcia-Irigoyen O, et al
    The anticoagulant Rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells.
    Hepatology. 2017 Jan 31. doi: 10.1002/hep.29084.
    PubMed     Text format     Abstract available


  92. WANG Y, Vincent R, Yang J, Asgharpour A, et al
    Dual photon microscopy based quantitation of fibrosis-related parameters (q-FP) to model disease progression in steatohepatitis.
    Hepatology. 2017 Jan 30. doi: 10.1002/hep.29090.
    PubMed     Text format     Abstract available


  93. VON LOEFFELHOLZ C, Lieske S, Neuschafer-Rube F, Willmes DM, et al
    The Human Longevity Gene Homolog INDY and Interleukin-6 Interact in Hepatic Lipid Metabolism.
    Hepatology. 2017 Jan 30. doi: 10.1002/hep.29089.
    PubMed     Text format     Abstract available


  94. GORDON-WEEKS AN, Lim SY, Yuzhalin AE, Jones K, et al
    Neutrophils Promote Hepatic Metastasis Growth Through fibroblast growth factor (FGF)2-dependent Angiogenesis.
    Hepatology. 2017 Jan 30. doi: 10.1002/hep.29088.
    PubMed     Text format     Abstract available


  95. HEIMBACH J, Kulik LM, Finn R, Sirlin CB, et al
    Aasld guidelines for the treatment of hepatocellular carcinoma.
    Hepatology. 2017 Jan 28. doi: 10.1002/hep.29086.
    PubMed     Text format    


  96. SHIMIZU Y, Peltzer N, Sevko A, Lafont E, et al
    The linear ubiquitin chain assembly complex acts as a liver tumor suppressor and inhibits hepatocyte apoptosis and hepatitis.
    Hepatology. 2017 Jan 24. doi: 10.1002/hep.29074.
    PubMed     Text format     Abstract available


  97. HARGROVE L, Kennedy L, Demieville J, Jones H, et al
    BDL-induced biliary hyperplasia, hepatic injury and fibrosis are reduced in mast cell deficient Kitw-sh mice.
    Hepatology. 2017 Jan 24. doi: 10.1002/hep.29079.
    PubMed     Text format     Abstract available


  98. STEINMETZ C, Kashyap A, Zhivkova N, Alizor H, et al
    Activation of SIRT1 by human chorionic gonadotropin exerts a therapeutic effect on hepatic injury and inflammation.
    Hepatology. 2017 Jan 21. doi: 10.1002/hep.29072.
    PubMed     Text format     Abstract available


  99. SABATE A, Blasi A
    Thromboelastography and blood product usage in cirrhosis with severe coagulopathy.
    Hepatology. 2017 Jan 19. doi: 10.1002/hep.29061.
    PubMed     Text format    


  100. VILLANUEVA C, Graupera I, Aracil C, Alvarado E, et al
    A Randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis.
    Hepatology. 2017 Jan 18. doi: 10.1002/hep.29056.
    PubMed     Text format     Abstract available


  101. DRIVER R, Rowe IA
    What is the benefit of early follow-up after hospitalization for patients with cirrhosis?
    Hepatology. 2017 Jan 18. doi: 10.1002/hep.29060.
    PubMed     Text format    


  102. ARORA P, Basu A, Schmidt ML, Clark GJ, et al
    NS5B Promotes Degradation of the NORE1A Tumor Suppressor to Facilitate Hepatitis C Virus Replication.
    Hepatology. 2017 Jan 16. doi: 10.1002/hep.29049.
    PubMed     Text format     Abstract available


  103. JOO EJ, Chang Y, Ryu S
    Response to NAFLD, hepatotropic viruses and cardio-metabolic risk.
    Hepatology. 2017 Jan 13. doi: 10.1002/hep.29048.
    PubMed     Text format    


  104. LONARDO A, Nascimbeni F, Ballestri S
    NAFLD, hepatotropic viruses and cardio-metabolic risk.
    Hepatology. 2017 Jan 13. doi: 10.1002/hep.29052.
    PubMed     Text format    


  105. LIN L, Ding Y, Wang Y, Wang Z, et al
    Functional lipidomics: palmitic acid impairs hepatocellular carcinoma development by modulating membrane fluidity and glucose metabolism.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29033.
    PubMed     Text format     Abstract available


  106. ATANASOVSKA B, Rensen SS, van der Sijde MR, Marsman G, et al
    A liver-specific long non-coding RNA with a role in cell viability is elevated in human non-alcoholic steatohepatitis.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29034.
    PubMed     Text format     Abstract available


  107. JANG JE, Park HS, Yoo HJ, Baek IJ, et al
    Protective role of endogenous plasmalogens against hepatic steatosis and steatohepatitis.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29039.
    PubMed     Text format     Abstract available


  108. LEFERE S, Hoorens A, Raevens S, Troisi R, et al
    Refractory subacute steatohepatitis after biliopancreatic diversion.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29038.
    PubMed     Text format     Abstract available


  109. BRUSCHI FV, Claudel T, Tardelli M, Caligiuri A, et al
    The PNPLA3 I148M variant modulates the fibrogenic phenotype of human hepatic stellate cells.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29041.
    PubMed     Text format     Abstract available


  110. PASTORE N, Attanasio S, Granese B, Teckman J, et al
    Activation of JNK pathway aggravates proteotoxicity of hepatic mutant Z alpha1-antitrypsin.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29035.
    PubMed     Text format     Abstract available


  111. YUE X, Ai J, Xu Y, Chen Y, et al
    Polymeric immunoglobulin receptor promotes tumor growth in hepatocellular carcinoma.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29036.
    PubMed     Text format     Abstract available


  112. ALKHOURI N, Feldstein AE
    Treating Nonalcoholic Steatohepatitis (NASH) in Children: Not a Cinch Task.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29043.
    PubMed     Text format     Abstract available


  113. STRAZZABOSCO M, Allen JI, Teisberg EO
    Value based care in hepatology.
    Hepatology. 2017 Jan 10. doi: 10.1002/hep.29042.
    PubMed     Text format     Abstract available


  114. VARRASSO G, Schiavetti A, Lanciotti S, Sapio M, et al
    Propranolol as First Line Treatment for Life-threatening Diffuse Infantile Hepatic Hemangioma: A Case Report.
    Hepatology. 2017 Jan 5. doi: 10.1002/hep.29028.
    PubMed     Text format    


  115. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2017;65:1-3.
    PubMed     Text format    


    December 2016
  116. SHUNG DL, Garcia-Tsao G
    Liver Capsule: Portal Hypertension and Varices: Pathogenesis, Stages and Management.
    Hepatology. 2016 Dec 29. doi: 10.1002/hep.29026.
    PubMed     Text format    


  117. LI N, Zhou ZS, Shen Y, Xu J, et al
    Inhibition of the SREBP pathway suppresses hepatocellular carcinoma through repressing inflammation.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29018.
    PubMed     Text format     Abstract available


  118. MCCOMMIS KS, Hodges WT, Brunt EM, Nalbantoglu I, et al
    Targeting the Mitochondrial Pyruvate Carrier Attenuates Fibrosis in a Mouse Model of Nonalcoholic Steatohepatitis.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29025.
    PubMed     Text format     Abstract available


  119. LI D, Liu X, Zhou J, Hu J, et al
    LncRNA HULC modulates the phosphorylation of YB-1 through serving as a scaffold of ERK and YB-1 to enhance hepatocarcinogenesis.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29010.
    PubMed     Text format     Abstract available


  120. TANDON P, Raman M, Mourtzakis M, Merli M, et al
    A Practical Approach to Nutritional Screening and Assessment in Cirrhosis.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29003.
    PubMed     Text format     Abstract available


  121. HAUSSINGER D, Keitel V
    Dual role of the bile acid receptor TGR5 for hepatic lipid metabolism in feast and famine.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29017.
    PubMed     Text format    


  122. WANG KS, Tiao G, Bass LM, Hertel PM, et al
    Analysis of surgical interruption of the enterohepatic circulation as a treatment for pediatric cholestasis.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29019.
    PubMed     Text format     Abstract available


  123. QIU YL, Gong JY, Feng JY, Wang RX, et al
    Defects in MYO5B are associated with a spectrum of previously undiagnosed low gamma-glutamyltransferase cholestasis.
    Hepatology. 2016 Dec 27. doi: 10.1002/hep.29020.
    PubMed     Text format     Abstract available


  124. CILLO U, Vitale A, Polacco M, Fasolo E, et al
    Liver transplantation for hepatocellular carcinoma through the lens of transplant benefit.
    Hepatology. 2016 Dec 23. doi: 10.1002/hep.28998.
    PubMed     Text format    


  125. AYUBI E, Safiri S, Sani M, Doosti-Irani A, et al
    Effect of Metabolic syndrome on cardiovascular, hepatic events and death in CHB patients: Methodological issues.
    Hepatology. 2016 Dec 23. doi: 10.1002/hep.29001.
    PubMed     Text format    


  126. BERZIGOTTI A, Albillos A, Villanueva C, Genesca J, et al
    Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The sportdiet study.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28992.
    PubMed     Text format     Abstract available


  127. MICHALOPOULOS GK
    Hepatostat: Liver regeneration and normal liver tissue maintenance.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28988.
    PubMed     Text format     Abstract available


  128. GUPTA R, Gupta J
    Strategies to improve survival of patients with intrahepatic cholangiocarcinoma undergoing liver transplantation.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28994.
    PubMed     Text format    


  129. SAPISOCHIN G, Bruix J
    In response to: Strategies to improve survival of patients with intrahepatic cholangiocarcinoma undergoing liver transplantation.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28993.
    PubMed     Text format    


  130. MORIS D, Felekouras E
    Ignore reality but not the consequences of its ignorance: Broaden Guidelines in surgery of Hepatocellular carcinoma.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28984.
    PubMed     Text format     Abstract available


  131. SAVALE L, Sattler C, Coilly A, Conti F, et al
    Long-term outcome in liver transplantation candidates with portopulmonary hypertension.
    Hepatology. 2016 Dec 20. doi: 10.1002/hep.28990.
    PubMed     Text format     Abstract available


  132. TAO J, Zhang R, Singh S, Poddar M, et al
    Targeting beta-catenin in hepatocellular cancers induced by co-expression of mutant beta-catenin and K-Ras in mice.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28975.
    PubMed     Text format     Abstract available


  133. BRIL F, Barb D, Portillo-Sanchez P, Biernacki D, et al
    Metabolic and Histological Implications of Intrahepatic Triglyceride Content in Nonalcoholic Fatty Liver Disease.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28985.
    PubMed     Text format     Abstract available


  134. MORZYGLOD L, Cauzac M, Popineau L, Denechaud PD, et al
    Grb14 inhibition triggers insulin-induced mouse hepatocyte proliferation and is associated with hepatocellular carcinoma.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28972.
    PubMed     Text format     Abstract available


  135. YAN FJ, Zhang XJ, Wang WX, Ji YX, et al
    The E3 ligase TRIM8 targets TAK1 to promote insulin resistance and steatohepatitis.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28971.
    PubMed     Text format     Abstract available


  136. KAFFE E, Katsifa A, Xylourgidis N, Ninou I, et al
    Hepatocyte Autotaxin expression promotes liver fibrosis and cancer.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28973.
    PubMed     Text format     Abstract available


  137. BUSCH CJ, Hendrikx T, Weismann D, Jackel S, et al
    Malondialdehyde epitopes are sterile mediators of hepatic inflammation in hypercholesterolemic mice.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28970.
    PubMed     Text format     Abstract available


  138. FAN W, Yang H, Liu T, Wang J, et al
    Prohibitin 1 Suppresses Liver Cancers Tumorigenesis in Mice and Human Hepatocellular and Cholangiocarcinoma cells.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28964.
    PubMed     Text format     Abstract available


  139. PRICE JC, Ma Y, Scherzer R, Korn N, et al
    HIV-infected and Uninfected Adults with Non-Genotype 3 Hepatitis C Virus Have Less Hepatic Steatosis than Adults with Neither Infection.
    Hepatology. 2016 Dec 16. doi: 10.1002/hep.28968.
    PubMed     Text format     Abstract available


  140. TAHARA Y, Shibata S
    Abnormal tuning of the hepatic circadian metabolic rhythms in lung cancer.
    Hepatology. 2016 Dec 10. doi: 10.1002/hep.28982.
    PubMed     Text format    


  141. HERNAEZ R, El-Serag H, DeBakey ME
    Hepatocellular Carcinoma Surveillance: The Road Ahead.
    Hepatology. 2016 Dec 10. doi: 10.1002/hep.28983.
    PubMed     Text format    



  142. 2016 Hepatology referees (volumes 63 and 64).
    Hepatology. 2016;64:2280-2285.
    PubMed     Text format    


  143. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2016;64:1829-1830.
    PubMed     Text format    


    November 2016
  144. VALDECANTOS MP, Pardo V, Ruiz L, Castro-Sanchez L, et al
    A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice.
    Hepatology. 2016 Nov 23. doi: 10.1002/hep.28962.
    PubMed     Text format     Abstract available


  145. KLEBANOFF MJ, Corey KE, Chhatwal J, Kaplan LM, et al
    Bariatric Surgery for Nonalcoholic Steatohepatitis: A Clinical and Cost-Effectiveness Analysis.
    Hepatology. 2016 Nov 23. doi: 10.1002/hep.28958.
    PubMed     Text format     Abstract available


  146. TRAN M, Wang L
    Preserving LXR by Inhibiting T39: A step closer to treating atherosclerosis and steatohepatitis?
    Hepatology. 2016 Nov 17. doi: 10.1002/hep.28946.
    PubMed     Text format    


  147. ASKGAARD G, Leon DA, Kjaer MS, Deleuran T, et al
    Risk for alcoholic liver cirrhosis after an initial hospital contact with alcohol problems: A nationwide prospective cohort study.
    Hepatology. 2016 Nov 16. doi: 10.1002/hep.28943.
    PubMed     Text format     Abstract available


  148. NEWBERRY EP, Xie Y, Kennedy SM, Graham MJ, et al
    Prevention of hepatic fibrosis with liver microsomal triglyceride transfer protein deletion in Liver fatty acid binding protein null mice.
    Hepatology. 2016 Nov 14. doi: 10.1002/hep.28941.
    PubMed     Text format     Abstract available


  149. VAN ASTEN M, Verhaegh P, Koek G, Verbeek J, et al
    The increasing burden of NAFLD fibrosis in the general population: Time to bridge the gap between hepatologists and primary care.
    Hepatology. 2016 Nov 10. doi: 10.1002/hep.28940.
    PubMed     Text format    


  150. CALDWELL S, Lisman T
    The cirrhotic platelet: Shedding light on an enigma.
    Hepatology. 2016 Nov 7. doi: 10.1002/hep.28931.
    PubMed     Text format    


  151. KIM JH, Sinn DH, Kang W, Gwak GY, et al
    Low-level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment.
    Hepatology. 2016 Nov 5. doi: 10.1002/hep.28916.
    PubMed     Text format     Abstract available


  152. YAN S, Tang J, Zhang Y, Wang Y, et al
    Prostaglandin E2 promotes hepatic bile acid synthesis by an E prostanoid receptor 3-mediated hepatocyte nuclear receptor 4alpha/cholesterol 7alpha-hydroxylase pathway in mice.
    Hepatology. 2016 Nov 5. doi: 10.1002/hep.28928.
    PubMed     Text format     Abstract available


  153. MASSEY VL, Dolin CE, Poole LG, Hudson SV, et al
    The hepatic "matrisome" responds dynamically to injury: Characterization of transitional changes to the extracellular matrix in mice.
    Hepatology. 2016 Nov 5. doi: 10.1002/hep.28918.
    PubMed     Text format     Abstract available


  154. NIU Y, Xu M, Slagle BL, Huang H, et al
    Farnesoid X receptor ablation sensitizes mice to hepatitis b virus X protein-induced hepatocarcinogenesis.
    Hepatology. 2016 Nov 5. doi: 10.1002/hep.28924.
    PubMed     Text format     Abstract available


  155. DESBOROUGH MJ, Kahan BC, Stanworth SJ, Jairath V, et al
    Fibrinogen as an independent predictor of mortality in decompensated cirrhosis and bleeding.
    Hepatology. 2016 Nov 3. doi: 10.1002/hep.28915.
    PubMed     Text format    


  156. DROLZ A, Fuhrmann V
    "Fibrinogen as an independent predictor of mortality in decompensated cirrhosis and bleeding".
    Hepatology. 2016 Nov 3. doi: 10.1002/hep.28914.
    PubMed     Text format    


  157. CAI WY, Lin LY, Hao H, Zhang SM, et al
    YAP-TEAD and HNF4alpha repress reciprocally to regulate hepatocarcinogenesis.
    Hepatology. 2016 Nov 3. doi: 10.1002/hep.28911.
    PubMed     Text format     Abstract available


  158. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2016;64:1395-1397.
    PubMed     Text format    


  159. QURESHI MA, Kim YO, Schuppan D
    Hepatocellular carcinoma in nonalcoholic fatty liver disease: A link between oxidative stress and T-cell suppression.
    Hepatology. 2016;64:1794-1797.
    PubMed     Text format    


  160. TAO J, Xu E, Zhao Y, Singh S, et al
    Modeling a human hepatocellular carcinoma subset in mice through coexpression of met and point-mutant beta-catenin.
    Hepatology. 2016;64:1587-1605.
    PubMed     Text format     Abstract available


    October 2016
  161. GARCIA-TSAO G, Abraldes J, Berzigotti A, Bosch J, et al
    Portal Hypertensive Bleeding in Cirrhosis: Risk Stratification, Diagnosis and Management - 2016 Practice Guidance by the American Association for the Study of Liver Diseases.
    Hepatology. 2016 Oct 27. doi: 10.1002/hep.28906.
    PubMed     Text format    


  162. KALAFATELI M, Wickham F, Burniston M, Cholongitas E, et al
    Development and validation of a mathematical equation to estimate glomerular filtration rate in cirrhosis: The rfh cirrhosis Gfr.
    Hepatology. 2016 Oct 25. doi: 10.1002/hep.28891.
    PubMed     Text format     Abstract available


  163. TANDON P, Reddy KR, O'Leary JG, Garcia-Tsao G, et al
    A Karnofsky performance status-based score predicts death after hospital discharge in patients with cirrhosis.
    Hepatology. 2016 Oct 24. doi: 10.1002/hep.28900.
    PubMed     Text format     Abstract available


  164. ATIQ O, Tiro J, Yopp AC, Muffler A, et al
    An Assessment of Benefits and Harms of Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
    Hepatology. 2016 Oct 24. doi: 10.1002/hep.28895.
    PubMed     Text format     Abstract available


  165. SUMAZIN P, Chen Y, Trevino LR, Sarabia SF, et al
    Genomic Analysis of Hepatoblastoma Identifies Distinct Molecular and Prognostic Subgroups.
    Hepatology. 2016 Oct 24. doi: 10.1002/hep.28888.
    PubMed     Text format     Abstract available


  166. KIMER N, Pedersen JS, Busk TM, Gluud LL, et al
    Rifaximin has no effect on hemodynamics in decompensated cirrhosis - A randomized, double blind, placebo controlled trial.
    Hepatology. 2016 Oct 24. doi: 10.1002/hep.28898.
    PubMed     Text format     Abstract available


  167. SUN Q, Loughran P, Shapiro R, Shrivastava IH, et al
    Redox-dependent regulation of hepatocyte AIM2 inflammasome activation in sterile liver injury in mice.
    Hepatology. 2016 Oct 24. doi: 10.1002/hep.28893.
    PubMed     Text format     Abstract available


  168. KE S, Chen S, Dong Z, Hong CS, et al
    Erythrocytosis in hepatocellular carcinoma portends poor prognosis by respiratory dysfunction secondary to mitochondrial DNA mutations.
    Hepatology. 2016 Oct 24. doi: 10.1002/hep.28889.
    PubMed     Text format     Abstract available


  169. LABONTE AC, Sung SJ, Jennelle LT, Dandekar AP, et al
    Expression of scavenger receptor-AI promotes alternative activation of murine macrophages to limit hepatic inflammation and fibrosis.
    Hepatology. 2016 Oct 22. doi: 10.1002/hep.28873.
    PubMed     Text format     Abstract available


  170. PARIKH ND, Marshall VD, Singal AG, Nathan H, et al
    Survival and Cost-Effectiveness of Sorafenib Therapy in Advanced Hepatocellular Carcinoma: An Analysis of the SEER-Medicare Database.
    Hepatology. 2016 Oct 22. doi: 10.1002/hep.28881.
    PubMed     Text format     Abstract available


  171. GARCIA-TSAO G
    Empowering Women - Perspective from a Hepatologist.
    Hepatology. 2016 Oct 22. doi: 10.1002/hep.28875.
    PubMed     Text format    


  172. BERGMANN J, Muller M, Baumann N, Reichert M, et al
    IL-6 trans-signaling is essential for the development of hepatocellular carcinoma.
    Hepatology. 2016 Oct 22. doi: 10.1002/hep.28874.
    PubMed     Text format     Abstract available


  173. MAROT A, Vandenbulcke H, Knebel JF, Doerig C, et al
    External validation of the nomogram for individualized prediction of HCC occurrence in patients with HCV-related compensated cirrhosis.
    Hepatology. 2016 Oct 13. doi: 10.1002/hep.28865.
    PubMed     Text format    


  174. HASLAM DB
    Non-alcoholic steatohepatitis and the intestinal microbiota.
    Hepatology. 2016 Oct 7. doi: 10.1002/hep.28864.
    PubMed     Text format    


  175. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2016;64:1011-3.
    PubMed     Text format    


    September 2016
  176. ALI KHAN M, Cholankeril G, Howden CW
    Are proton pump inhibitors a threat for spontaneous bacterial peritonitis and hepatic encephalopathy in cirrhosis? Not so fast.
    Hepatology. 2016 Sep 30. doi: 10.1002/hep.28858.
    PubMed     Text format    


  177. LAINE F, Ruivard M, Loustaud-Ratti V, Bonnet F, et al
    Metabolic and hepatic effects of bloodletting in dysmetabolic iron overload syndrome: A randomized controlled study in 274 patients.
    Hepatology. 2016 Sep 29. doi: 10.1002/hep.28856.
    PubMed     Text format     Abstract available


  178. CHENG JY, Wong VW, Tse YK, Chim AM, et al
    Metabolic syndrome increases cardiovascular event but not hepatic event and death in patients with chronic hepatitis B.
    Hepatology. 2016 Sep 29. doi: 10.1002/hep.28778.
    PubMed     Text format     Abstract available


  179. PONZETTO A, Srinivasan RS
    Risk factors for hepatocellular carcinoma.
    Hepatology. 2016 Sep 28. doi: 10.1002/hep.28854.
    PubMed     Text format    


  180. LO GH
    The risk of bleeding after invasive procedures in cirrhotics with severe coagulopathy.
    Hepatology. 2016 Sep 26. doi: 10.1002/hep.28855.
    PubMed     Text format    


  181. CUSI K
    Nonalcoholic Steatohepatitis in Non-Obese Patients: Not So Different After All.
    Hepatology. 2016 Sep 20. doi: 10.1002/hep.28839.
    PubMed     Text format    


  182. RAPARELLI V, Basili S, Carnevale R, Napoleone L, et al
    Low-grade endotoxemia and platelet activation in cirrhosis.
    Hepatology. 2016 Sep 19. doi: 10.1002/hep.28853.
    PubMed     Text format     Abstract available


  183. LI D, Li W, Hui L
    Hybrid hepatocyte: A newly identified player for regeneration in hepatic injuries.
    Hepatology. 2016 Sep 19. doi: 10.1002/hep.28837.
    PubMed     Text format     Abstract available


  184. MULLIGAN DC
    The ongoing quest to find the appropriate patients to transplant with hepatocellular carcinoma: Milan to san Francisco to Toronto and beyond.
    Hepatology. 2016 Sep 19. doi: 10.1002/hep.28841.
    PubMed     Text format    


  185. AMARAPURKAR D, Somani V, Shah A
    Do we need to correct coagulation abnormalities prophylactically in cirrhotics undergoing invasive procedures? - A Dilemma.
    Hepatology. 2016 Sep 17. doi: 10.1002/hep.28830.
    PubMed     Text format    


  186. EGUCHI A, Lazaro RG, Wang J, Kim J, et al
    Extracellular vesicles released by hepatocytes from gastric infusion model of ALD contain a miRNA barcode that can be detected in blood.
    Hepatology. 2016 Sep 17. doi: 10.1002/hep.28838.
    PubMed     Text format     Abstract available


  187. GASTALDELLI A, Gaggini M, Daniele G, Ciociaro D, et al
    Exenatide improves both hepatic and adipose tissue insulin resistance: A dynamic PET study.
    Hepatology. 2016 Sep 17. doi: 10.1002/hep.28827.
    PubMed     Text format     Abstract available


  188. ABRALDES JG, Bureau C, Stefanescu H, Augustin S, et al
    Non-invasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The "Anticipate" study.
    Hepatology. 2016 Sep 17. doi: 10.1002/hep.28824.
    PubMed     Text format     Abstract available


  189. AZZARITI A, Mancarella S, Porcelli L, Elisa Quatrale A, et al
    Hepatic Stellate Cells Induce HCC Cell Resistance to Sorafenib through the Laminin-332/alpha3 Integrin Axis recovery of FAK Ubiquitination.
    Hepatology. 2016 Sep 17. doi: 10.1002/hep.28835.
    PubMed     Text format     Abstract available


  190. TANAKA S, Hikita H, Tatsumi T, Sakamori R, et al
    Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease.
    Hepatology. 2016 Sep 16. doi: 10.1002/hep.28820.
    PubMed     Text format     Abstract available


  191. KAMINSKY P, Preiss J, Sasatomi E, Gerber DA, et al
    Biliary Adenofibroma: A Rare Hepatic Lesion with Malignant Features.
    Hepatology. 2016 Sep 15. doi: 10.1002/hep.28818.
    PubMed     Text format    


  192. RUSSO MW, Koteish A, Fuchs M, Reddy G, et al
    Workforce in Hepatology: Update and a critical need for more information.
    Hepatology. 2016 Sep 15. doi: 10.1002/hep.28810.
    PubMed     Text format     Abstract available


  193. HO CM, Chen HL
    Expression of Glutamine Synthetase in Hepatocyte Progenitor Cells Derived from Canal of Hering.
    Hepatology. 2016 Sep 12. doi: 10.1002/hep.28805.
    PubMed     Text format    


  194. TREVISANI F, Bucci L, Garuti F
    Is it time to extend criteria for hepatic resection in the treatment of hepatocellular carcinoma?
    Hepatology. 2016 Sep 12. doi: 10.1002/hep.28804.
    PubMed     Text format    


  195. SOLINAS A, Calvisi DF
    PD-L1 expression in hepatocellular carcinoma: A prognostic marker and therapeutic target for liver cancer?
    Hepatology. 2016 Sep 12. doi: 10.1002/hep.28803.
    PubMed     Text format    


  196. RENOU C, Lesgourgues B, Macaigne G, Pauwels A, et al
    Hepatitis E in decompensated alcoholic cirrhosis.
    Hepatology. 2016 Sep 12. doi: 10.1002/hep.28792.
    PubMed     Text format    


  197. PASCALE RM, Feo F, Calvisi DF
    An infernal crosstalk between oncogenic beta-catenin and c-Met in hepatocellular carcinoma: Evidence from mouse modeling.
    Hepatology. 2016 Sep 6. doi: 10.1002/hep.28790.
    PubMed     Text format    


  198. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2016;64:703-5.
    PubMed     Text format    


    August 2016
  199. TORNER A, Stokkeland K, Svensson A, Dickman PW, et al
    The underreporting of hepatocellular carcinoma to the Cancer Register and a log-linear model to estimate a more correct incidence.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28775.
    PubMed     Text format     Abstract available


  200. OKABE H, Yang J, Sylakowski K, Yovchev M, et al
    Wnt signaling regulates hepatobiliary repair following cholestatic liver injury in mice.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28774.
    PubMed     Text format     Abstract available


  201. LAUSCHKE VM, Vorrink SU, Moro SM, Reyazee F, et al
    Massive rearrangements of cellular miRNA signatures are key drivers of hepatocyte dedifferentiation.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28780.
    PubMed     Text format     Abstract available


  202. LALEMAN W, Trebicka J, Verbeke L
    Evolving insights in the pathophysiology of complications of cirrhosis: The Farnesoid-X receptor (FXR) to the rescue?
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28771.
    PubMed     Text format    


  203. FARVARDIN S, Patel J, Khambaty M, Yerokun OA, et al
    Patient-Reported Barriers are Associated with Lower HCC Surveillance Rates in Patients with Cirrhosis.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28770.
    PubMed     Text format     Abstract available


  204. SALLOUM S, Holmes JA, Jindal R, Bale SS, et al
    HIV/HCV in hepatic and stellate cell lines reveals cooperative profibrotic transcriptional activation between viruses and cell types.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28766.
    PubMed     Text format     Abstract available


  205. GOLDBERG DS, Taddei TH, Serper M, Mehta R, et al
    Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28765.
    PubMed     Text format     Abstract available


  206. CHEN HA, Kuo TC, Tseng CF, Ma JT, et al
    ANGPTL1 Antagonizes MET Receptor Activity to Repress Sorafenib Resistance and Cancer Stemness in Hepatocellular Carcinoma Cells.
    Hepatology. 2016 Aug 17. doi: 10.1002/hep.28773.
    PubMed     Text format     Abstract available


  207. CLERBAUX LA, Manco R, Leclercq I
    Upstream regulators of hepatic Wnt/beta-catenin activity control liver metabolic zonation, development and regeneration.
    Hepatology. 2016 Aug 12. doi: 10.1002/hep.28763.
    PubMed     Text format    


  208. MIKOLAJCZYK AE, Farnan JM, McConville JF, Jensen DM, et al
    Novel Educational Interventions in Residency Increase Knowledge of Chronic Liver Disease and Career Interest in Hepatology.
    Hepatology. 2016 Aug 10. doi: 10.1002/hep.28741.
    PubMed     Text format     Abstract available


  209. BIHARI C, Anand L, Rooge S, Kumar D, et al
    Bone Marrow Stem Cells and its Niche Components are Adversely Affected in Advanced Cirrhosis of Liver.
    Hepatology. 2016 Aug 3. doi: 10.1002/hep.28754.
    PubMed     Text format     Abstract available


  210. CLARIA J, Stauber RE, Coenraad MJ, Moreau R, et al
    systemic inflammation in decompensated cirrhosis. Characterization and role in acute-on-chronic liver failure.
    Hepatology. 2016 Aug 2. doi: 10.1002/hep.28740.
    PubMed     Text format     Abstract available


  211. DROLZ A, Fuhrmann V
    Reply to "Anticoagulation with i.v. unfractionated heparin and major bleeding in cirrhosis".
    Hepatology. 2016 Aug 2. doi: 10.1002/hep.28757.
    PubMed     Text format    


  212. SAPISOCHIN G, Facciuto M, Rubbia-Brandt L, Marti J, et al
    Liver transplantation for "very early" intrahepatic cholangiocarcinoma. international retrospective study supporting a prospective assessment.
    Hepatology. 2016 Aug 2. doi: 10.1002/hep.28744.
    PubMed     Text format     Abstract available


  213. HU W, Zhang W, Chen Y, Rana U, et al
    Nogo-B receptor deficiency increases LXRalpha nuclear translocation and hepatic lipogenesis via an AMPKalpha-dependent pathway.
    Hepatology. 2016 Aug 2. doi: 10.1002/hep.28747.
    PubMed     Text format     Abstract available



  214. Correction: Mixed lineage kinase 3 mediates release of C-X-C motif ligand 10-bearing chemotactic extracellular vesicles from lipotoxic hepatocytes.
    Hepatology. 2016;64:702.
    PubMed     Text format    


  215. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2016;64:325-7.
    PubMed     Text format    


    July 2016
  216. QI X, De Stefano V, Guo X
    Anticoagulation with i.v. unfractionated heparin and major bleeding in cirrhosis.
    Hepatology. 2016 Jul 30. doi: 10.1002/hep.28743.
    PubMed     Text format    


  217. DAM G, Vilstrup H, Watson H, Jepsen P, et al
    Proton Pump Inhibitors as a Risk Factor for Hepatic Encephalopathy and Spontaneous Bacterial Peritonitis in Cirrhosis Patients With Ascites.
    Hepatology. 2016 Jul 30. doi: 10.1002/hep.28737.
    PubMed     Text format     Abstract available


  218. LI L, Piontek K, Ishida M, Fausther M, et al
    Extracellular vesicles carry miR-195 to intrahepatic cholangiocarcinoma and improve survival in a rat model.
    Hepatology. 2016 Jul 30. doi: 10.1002/hep.28735.
    PubMed     Text format     Abstract available


  219. MAROT A, Trepo E, Doerig C, Moreno C, et al
    SEMS should be considered in patients with cirrhosis and uncontrolled variceal bleeding.
    Hepatology. 2016 Jul 30. doi: 10.1002/hep.28738.
    PubMed     Text format    


  220. DUNCAN SA
    Multipotent stem cells and their lineage restriction to hepatocytes.
    Hepatology. 2016 Jul 12. doi: 10.1002/hep.28727.
    PubMed     Text format    


  221. SUGIYAMA M, Kanto T
    Dual blockade of HCV entry at a gatekeeper of hepatocytes - Not only a preventive but also therapeutic target of CLDN-1.
    Hepatology. 2016 Jul 12. doi: 10.1002/hep.28726.
    PubMed     Text format    


  222. PORAT-SHLIOM N, Tietgens AJ, Van Itallie CM, Vitale-Cross L, et al
    Liver Kinase B1 regulates hepatocellular tight junction distribution and function in vivo.
    Hepatology. 2016 Jul 11. doi: 10.1002/hep.28724.
    PubMed     Text format     Abstract available


  223. KOPPE C, Verheugd P, Gautheron J, Reisinger F, et al
    IKKalpha/beta control biliary homeostasis and hepatocarcinogenesis in mice by phosphorylating the cell-death mediator RIPK1.
    Hepatology. 2016 Jul 11. doi: 10.1002/hep.28723.
    PubMed     Text format     Abstract available


  224. LANGBERG KM, Taddei TH
    Balancing quality with quantity: The role of palliative care in managing decompensated cirrhosis.
    Hepatology. 2016 Jul 7. doi: 10.1002/hep.28717.
    PubMed     Text format    


  225. DUFOUR JF
    Hepatology Highlights.
    Hepatology. 2016;64:1-3.
    PubMed     Text format    


    June 2016
  226. CUERVO H, Nielsen CM, Simonetto DA, Ferrell L, et al
    Endothelial Notch signaling is essential to prevent hepatic vascular malformations in mice.
    Hepatology. 2016 Jun 30. doi: 10.1002/hep.28713.
    PubMed     Text format     Abstract available


  227. CALDERARO J, Rousseau B, Amaddeo G, Mercey M, et al
    PD-L1 expression in hepatocellular carcinoma: Relationship with clinical and pathological features.
    Hepatology. 2016 Jun 30. doi: 10.1002/hep.28710.
    PubMed     Text format     Abstract available


  228. WU D, Liu G, Liu Y, Saiyin H, et al
    Zinc finger protein 191 inhibits hepatocellular carcinoma metastasis via discs large 1-mediated yes associated protein inactivation.
    Hepatology. 2016 Jun 30. doi: 10.1002/hep.28708.
    PubMed     Text format     Abstract available


  229. DONEPUDI AC, Boehme S, Li F, Chiang JY, et al
    G protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis.
    Hepatology. 2016 Jun 28. doi: 10.1002/hep.28707.
    PubMed     Text format     Abstract available


  230. KALAMBOKIS GN, Oikonomou A, Christou L, Baltayiannis G, et al
    High von Willebrand factor antigen levels and procoagulant imbalance may be involved in both increasing severity of cirrhosis and portal vein thrombosis.
    Hepatology. 2016 Jun 27. doi: 10.1002/hep.28703.
    PubMed     Text format    


  231. GANNE-CARRIE N, Layese R, Bourcier V, Cagnot C, et al
    Nomogram for individualized prediction of hepatocellular carcinoma occurrence in HCV-cirrhosis (ANRS CO12 CirVir).
    Hepatology. 2016 Jun 27. doi: 10.1002/hep.28702.
    PubMed     Text format     Abstract available


  232. HANNAH WN JR, Harrison SA
    Non-invasive Imaging Methods to Determine Severity of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
    Hepatology. 2016 Jun 24. doi: 10.1002/hep.28699.
    PubMed     Text format     Abstract available


  233. KANG DJ, Betrapally NS, Ghosh SA, Sartor RB, et al
    Gut microbiota drive the development of neuro-inflammatory response in cirrhosis.
    Hepatology. 2016 Jun 23. doi: 10.1002/hep.28696.
    PubMed     Text format     Abstract available


  234. SUK KT, Yoon JH, Kim MY, Kim CW, et al
    Transplantation with Autologous Bone Marrow-Derived Mesenchymal Stem Cells for Alcoholic Cirrhosis: Phase 2 Trial.
    Hepatology. 2016 Jun 23. doi: 10.1002/hep.28693.
    PubMed     Text format     Abstract available


  235. ZHANG H, Xing Z, Mani SK, Bancel B, et al
    RNA helicase DDX5 regulates PRC2/HOTAIR function in Hepatitis B Virus infection and hepatocarcinogenesis.
    Hepatology. 2016 Jun 23. doi: 10.1002/hep.28698.
    PubMed     Text format     Abstract available


  236. CUI J, Chen CH, Lo MT, Schork N, et al
    Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study.
    Hepatology. 2016 Jun 17. doi: 10.1002/hep.28674.
    PubMed     Text format     Abstract available


  237. DI PASCOLI M, Zampieri F, Verardo A, Pesce P, et al
    Inhibition of EETs production in cirrhotic rats has beneficial effects on portal hypertension by reducing splanchnic vasodilation.
    Hepatology. 2016 Jun 16. doi: 10.1002/hep.28686.
    PubMed     Text format     Abstract available


  238. THOMSEN MK, Nandakumar R, Stadler D, Malo A, et al
    Lack of immunological DNA sensing in hepatocytes facilitates hepatitis B virus infection.
    Hepatology. 2016 Jun 16. doi: 10.1002/hep.28685.
    PubMed     Text format     Abstract available


  239. PLOEGER C, Waldburger N, Fraas A, Goeppert B, et al
    Chromosome 8p tumor suppressor genes SH2D4A and SORBS3 cooperate to inhibit interleukin-6 signaling in hepatocellular carcinoma.
    Hepatology. 2016 Jun 16. doi: 10.1002/hep.28684.
    PubMed     Text format     Abstract available


  240. SETIAWAN VW, Stram DO, Porcel J, Lu SC, et al
    Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The Multiethnic Cohort.
    Hepatology. 2016 Jun 15. doi: 10.1002/hep.28677.
    PubMed     Text format     Abstract available


  241. MARQUARDT JU
    Deconvolution of the cellular origin in hepatocellular carcinoma - hepatocytes take the center stage.
    Hepatology. 2016 Jun 10. doi: 10.1002/hep.28671.
    PubMed     Text format    


  242. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2016;63:1749-1751.
    PubMed     Text format    


    May 2016
  243. INZAUGARAT ME, Wree A, Feldstein AE
    Hepatocyte mitochondrial DNA released in microparticles and TLR9 activation: A link between lipotoxicity and inflammation during NASH.
    Hepatology. 2016 May 30. doi: 10.1002/hep.28666.
    PubMed     Text format    


  244. CHIU DK, Xu IM, Lai RK, Tse AP, et al
    Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28655.
    PubMed     Text format     Abstract available


  245. SUNG FY, Lan CY, Huang CJ, Lin CL, et al
    Progressive accumulation of mutations in the hepatitis B virus genome and its impact for time to diagnosis of hepatocellular carcinoma.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28654.
    PubMed     Text format     Abstract available


  246. ZEISEL MB, Baumert TF
    Translation and protein expression of lncRNAs: Impact for liver disease and hepatocellular carcinoma.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28653.
    PubMed     Text format    


  247. IWAKIRI Y
    The Lymphatic system: A new frontier in hepatology.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28650.
    PubMed     Text format    


  248. MATSUURA K, De Giorgi V, Schechterly C, Wang RY, et al
    Circulating let-7 levels in plasma and extracellular vesicles correlate with hepatic fibrosis progression in chronic hepatitis C.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28660.
    PubMed     Text format     Abstract available


  249. LEE SA, Yuen JJ, Jiang H, Kahn BB, et al
    Adipocyte-specific over-expression of retinol-binding protein 4 (RBP4) causes hepatic steatosis in mice.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28659.
    PubMed     Text format     Abstract available


  250. ZOU Y, Li G, Wang L
    Colony-stimulating factor 1 should be considered when studying the miR-28-5p-IL-34-macrophage feedback loop in hepatocellular carcinoma.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28658.
    PubMed     Text format    


  251. HAPPERTS S, Foucault A, Billiard JS, Nguyen B, et al
    Combined hepatocellular-cholangiocarcinoma in a patient with Abernethy malformation and Tetralogy of Fallot - A case report.
    Hepatology. 2016 May 26. doi: 10.1002/hep.28656.
    PubMed     Text format    


  252. PIANO S, Angeli P
    Terlipressin administration for type 1 hepatorenal syndrome. More answers than open questions.
    Hepatology. 2016 May 17. doi: 10.1002/hep.28648.
    PubMed     Text format    


  253. HEWETT LJ, Bradshaw ML, Gordon LL, Rockey DC, et al
    Diagnosis of isolated hepatic hydrothorax using peritoneal scintigraphy.
    Hepatology. 2016 May 14. doi: 10.1002/hep.28634.
    PubMed     Text format    


  254. SAPISOCHIN G, Goldaracena N, Laurence JM, Dib M, et al
    The extended toronto criteria for liver transplantation in patients with hepatocellular carcinoma: A prospective validation study.
    Hepatology. 2016 May 14. doi: 10.1002/hep.28643.
    PubMed     Text format     Abstract available


  255. WAN ZY, Tian JS, Tan HW, Chow AL, et al
    Mechanistic target of rapamycin complex 1 (mTORC1) is an essential mediator of metabolic and mitogenic effects of FGF19 in hepatoma cells.
    Hepatology. 2016 May 14. doi: 10.1002/hep.28639.
    PubMed     Text format     Abstract available


  256. LI D, Fu J, Du M, Zhang H, et al
    Hepatocellular carcinoma repression by TNFalpha-mediated synergistic lethal effect of mitosis defect-induced senescence and cell death sensitization.
    Hepatology. 2016 May 14. doi: 10.1002/hep.28637.
    PubMed     Text format     Abstract available


  257. LIU M, Chen L, Ma NF, Chow RK, et al
    CHD1L promotes lineage reversion of hepatocellular carcinoma through opening chromatin for key developmental transcription factors.
    Hepatology. 2016;63:1544-1559.
    PubMed     Text format     Abstract available


  258. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2016;63:1405-1407.
    PubMed     Text format    


  259. VALANEJAD L, Timchenko N
    Akt-FoxO1 axis controls liver regeneration.
    Hepatology. 2016;63:1424-6.
    PubMed     Text format    


  260. BEZERRA JA
    MDR3 mutation analysis: A step closer to precision medicine.
    Hepatology. 2016;63:1421-3.
    PubMed     Text format    


  261. BLOKS VW, Plosch T, Jonker JW, Kuipers F, et al
    Reply to: "Impaired expression of multidrug resistance-associated protein 2 and liver damage in erythropoietic protoporphyria".
    Hepatology. 2016;63:1743-4.
    PubMed     Text format    


  262. SCHWIMMER JB
    Clinical advances in pediatric nonalcoholic fatty liver disease.
    Hepatology. 2016;63:1718-25.
    PubMed     Text format    


  263. LIASKOU E, Klemsdal Henriksen EK, Holm K, Kaveh F, et al
    High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires.
    Hepatology. 2016;63:1608-19.
    PubMed     Text format     Abstract available


    April 2016
  264. DROLZ A, Horvatits T, Roedl K, Rutter K, et al
    Coagulation parameters and major bleeding in critically ill patients with cirrhosis.
    Hepatology. 2016 Apr 28. doi: 10.1002/hep.28628.
    PubMed     Text format     Abstract available


  265. HSIN IF, Montano E, Seki E
    Finding a new role for NEMO: A key player in preventing hepatocyte apoptosis and liver tumorigenesis by inhibiting RIPK1.
    Hepatology. 2016 Apr 27. doi: 10.1002/hep.28627.
    PubMed     Text format    


  266. TANG H, Bai HX, Su C, Lee AM, et al
    The effect of cirrhosis on radiogenomic biomarker's ability to predict microvascular invasion and outcome in hepatocellular carcinoma.
    Hepatology. 2016 Apr 26. doi: 10.1002/hep.28620.
    PubMed     Text format    


  267. MALIZIA G, Cervello OV, D'Amico G
    Statins in cirrhosis: The magic pill?
    Hepatology. 2016 Apr 26. doi: 10.1002/hep.28616.
    PubMed     Text format    


  268. SHIN S, Wangensteen KJ, Teta-Bissett M, Wang YJ, et al
    Genetic Lineage Tracing Analysis of the Cell of Origin of Hepatotoxin-Induced Liver Tumors in Mice.
    Hepatology. 2016 Apr 21. doi: 10.1002/hep.28602.
    PubMed     Text format     Abstract available


  269. CHENG AL, Thongprasert S, Lim HY, Sukeepaisarnjaroen W, et al
    Randomized, Open-Label Phase 2 Study Comparing Frontline Dovitinib vs Sorafenib in Patients With Advanced Hepatocellular Carcinoma.
    Hepatology. 2016 Apr 15. doi: 10.1002/hep.28600.
    PubMed     Text format     Abstract available


  270. GLUUD LL, Vilstrup H, Morgan MY
    Non-Absorbable Disaccharides for Hepatic Encephalopathy: A Systematic Review and Meta-Analysis.
    Hepatology. 2016 Apr 15. doi: 10.1002/hep.28598.
    PubMed     Text format     Abstract available


  271. ARRIVE L, Zucman-Rossi J, Balladur P, Wendum D, et al
    Hepatocellular adenoma with malignant transformation in a patient with neonatal portal vein thrombosis.
    Hepatology. 2016 Apr 4. doi: 10.1002/hep.28590.
    PubMed     Text format    



  272. Correction: Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
    Hepatology. 2016;63:1403.
    PubMed     Text format    


  273. CUBERO FJ
    Shutting off inflammation: A novel switch on hepatic stellate cells.
    Hepatology. 2016;63:1086-9.
    PubMed     Text format    


  274. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2016;63:1065-7.
    PubMed     Text format    


  275. MOLLER S
    Toward new standards for noninvasive measuring of portal pressure?
    Hepatology. 2016;63:1384-6.
    PubMed     Text format    


  276. VINCIGUERRA M, Mazzoccoli G
    Aryl hydrocarbon receptor-fibroblast growth factor 21 dissociation of fatty liver from insulin resistance: A timely matter?
    Hepatology. 2016;63:1396-7.
    PubMed     Text format    


  277. LU P, Xie W
    Reply.
    Hepatology. 2016;63:1397-8.
    PubMed     Text format    


  278. STEFANESCU H, Lupsor-Platon M, Badea RI
    The devil's triangle of steatosis, obesity, and liver stiffness.
    Hepatology. 2016;63:1392-3.
    PubMed     Text format    


  279. PETTA S, Craxi A
    Reply.
    Hepatology. 2016;63:1394.
    PubMed     Text format    


  280. TAPPER EB, Lai M
    Weight loss results in significant improvements in quality of life for patients with nonalcoholic fatty liver disease: A prospective cohort study.
    Hepatology. 2016;63:1184-9.
    PubMed     Text format     Abstract available


  281. UNALP-ARIDA A, Ruhl CE
    Noninvasive fatty liver markers predict liver disease mortality in the U.S. population.
    Hepatology. 2016;63:1170-83.
    PubMed     Text format     Abstract available


  282. GUAL P, Postic C
    Therapeutic potential of nicotinamide adenine dinucleotide for nonalcoholic fatty liver disease.
    Hepatology. 2016;63:1074-7.
    PubMed     Text format    


  283. THORGEIRSSON SS
    Stemness and reprogramming in liver cancer.
    Hepatology. 2016;63:1068-70.
    PubMed     Text format    


  284. GARIANI K, Menzies KJ, Ryu D, Wegner CJ, et al
    Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice.
    Hepatology. 2016;63:1190-204.
    PubMed     Text format     Abstract available


  285. SHNEIDER BL, de Ville de Goyet J, Leung DH, Srivastava A, et al
    Primary prophylaxis of variceal bleeding in children and the role of MesoRex Bypass: Summary of the Baveno VI Pediatric Satellite Symposium.
    Hepatology. 2016;63:1368-80.
    PubMed     Text format     Abstract available


  286. PIANO S, Fasolato S, Salinas F, Romano A, et al
    The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial.
    Hepatology. 2016;63:1299-309.
    PubMed     Text format     Abstract available


    March 2016
  287. SERLIE MJ, Ter Horst KW, Brown AW
    Addendum: Hypercaloric diets with high meal frequency, but not increased meal size, increase intrahepatic triglycerides: A randomized controlled trial.
    Hepatology. 2016 Mar 31. doi: 10.1002/hep.28588.
    PubMed     Text format    


  288. KAI AK, Chan LK, Lo RC, Lee JM, et al
    Downregulation of TIMP2 via HIF-1alpha/miR-210/HIF-3alpha regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma.
    Hepatology. 2016 Mar 28. doi: 10.1002/hep.28577.
    PubMed     Text format     Abstract available


  289. KALAMBOKIS GN, Christodoulou D, Baltayiannis G, Christou L, et al
    Propranolol use beyond 6 months increases mortality in patients with Child-Pugh C cirrhosis and ascites.
    Hepatology. 2016 Mar 26. doi: 10.1002/hep.28575.
    PubMed     Text format    


  290. ARAB JP, Shah VH
    Statins and portal hypertension: A tale of two models.
    Hepatology. 2016 Mar 25. doi: 10.1002/hep.28567.
    PubMed     Text format    


  291. REZVANI M, Grimm A, Willenbring H
    Assessing the Therapeutic Potential of Lab-Made Hepatocytes.
    Hepatology. 2016 Mar 25. doi: 10.1002/hep.28569.
    PubMed     Text format     Abstract available


  292. MARRONE J, Soria LR, Danielli M, Lehmann GL, et al
    Hepatic Gene Transfer of Human Aquaporin-1 Improves Bile Salt Secretory Failure in Rats with Estrogen-Induced Cholestasis.
    Hepatology. 2016 Mar 21. doi: 10.1002/hep.28564.
    PubMed     Text format     Abstract available


  293. KANWAL F, Asch SM, Kramer JR, Cao Y, et al
    Early Outpatient Follow-up and 30-day Outcomes in Patients Hospitalized with Cirrhosis.
    Hepatology. 2016 Mar 17. doi: 10.1002/hep.28558.
    PubMed     Text format     Abstract available


  294. RAO Q, Zuo B, Lu Z, Gao X, et al
    Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and human in vitro.
    Hepatology. 2016 Mar 17. doi: 10.1002/hep.28549.
    PubMed     Text format     Abstract available


  295. TAKASHIMA Y, Terada M, Udono M, Miura S, et al
    Suppression of let-7b and miR-125a/b maturation by Lin28b enables maintenance of stem cell properties in hepatoblasts.
    Hepatology. 2016 Mar 17. doi: 10.1002/hep.28548.
    PubMed     Text format     Abstract available


  296. BISSONNETTE J, Garcia-Pagan JC, Albillos A, Turon F, et al
    Role of the Transjugular Intrahepatic Portosystemic Shunt in the Management of Severe Complications of Portal Hypertension in Idiopathic Noncirrhotic Portal Hypertension.
    Hepatology. 2016 Mar 17. doi: 10.1002/hep.28547.
    PubMed     Text format     Abstract available


  297. TREVISANI F, Golfieri R
    Lipiodol transarterial chemoembolization for hepatocellular carcinoma: Where are we now?
    Hepatology. 2016 Mar 16. doi: 10.1002/hep.28554.
    PubMed     Text format    


  298. MCPHAIL MJ, Auzinger G, Bernal W, Wendon JA, et al
    Decisions on futility in patients with cirrhosis and organ failure.
    Hepatology. 2016 Mar 7. doi: 10.1002/hep.28539.
    PubMed     Text format    


  299. GUSTOT T, Fernandez J, Pavesi M, Arroyo V, et al
    Reply to "Decisions on futility in patients with cirrhosis and organ failure".
    Hepatology. 2016 Mar 7. doi: 10.1002/hep.28538.
    PubMed     Text format    


  300. ABRALDES JG, Burak KW
    STAT order: Should patients with chronic liver disease be prescribed statins to prevent fibrosis progression and hepatocellular carcinoma?
    Hepatology. 2016 Mar 4. doi: 10.1002/hep.28537.
    PubMed     Text format    


  301. EL-SERAG HB, Kanwal F, Richardson P, Kramer J, et al
    Risk of Hepatocellular Carcinoma after Sustained Virologic Response in Veterans with HCV-infection.
    Hepatology. 2016 Mar 4. doi: 10.1002/hep.28535.
    PubMed     Text format     Abstract available



  302. Correction: Characterization of the genotype and integration patterns of hepatitis B virus in early- and late-onset hepatocellular carcinoma.
    Hepatology. 2016;63:1064.
    PubMed     Text format    



  303. Correction: Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition via Akt/GSK-3beta/snail signaling.
    Hepatology. 2016;63:1064.
    PubMed     Text format    


  304. SAMARIN J, Laketa V, Malz M, Roessler S, et al
    PI3K/AKT/mTOR-dependent stabilization of oncogenic far-upstream element binding proteins in hepatocellular carcinoma cells.
    Hepatology. 2016;63:813-26.
    PubMed     Text format     Abstract available


  305. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2016;63:679-81.
    PubMed     Text format    


  306. GUY CD, Diehl AM
    Reply.
    Hepatology. 2016;63:1057-8.
    PubMed     Text format    


  307. ROMAGNOLI R, Mazzaferro V, Bruix J
    Reply.
    Hepatology. 2016;63:1054-5.
    PubMed     Text format    


  308. BOHM M, Vuppalanchi R, Chalasani N
    Febuxostat-induced acute liver injury.
    Hepatology. 2016;63:1047-9.
    PubMed     Text format    


  309. MANN JP, De Vito R, Mosca A, Alisi A, et al
    Portal inflammation is independently associated with fibrosis and metabolic syndrome in pediatric nonalcoholic fatty liver disease.
    Hepatology. 2016;63:745-53.
    PubMed     Text format     Abstract available


  310. LEE YH, Kim SU, Song K, Park JY, et al
    Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008-2011).
    Hepatology. 2016;63:776-86.
    PubMed     Text format     Abstract available


  311. DIBRA D, Xia X, Mitra A, Cutrera JJ, et al
    Mutant p53 in concert with an interleukin-27 receptor alpha deficiency causes spontaneous liver inflammation, fibrosis, and steatosis in mice.
    Hepatology. 2016;63:1000-12.
    PubMed     Text format     Abstract available


  312. DONATI B, Motta BM, Pingitore P, Meroni M, et al
    The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage.
    Hepatology. 2016;63:787-98.
    PubMed     Text format     Abstract available


  313. BOURSIER J, Mueller O, Barret M, Machado M, et al
    The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.
    Hepatology. 2016;63:764-75.
    PubMed     Text format     Abstract available


  314. BJORNSSON ES, Olafsson JH
    Concomitant drug-induced liver and skin reactions: An Indian experience.
    Hepatology. 2016;63:700-2.
    PubMed     Text format    


  315. SENIOR JR
    Can rechallenge be done safely after mild or moderate drug-induced liver injury?
    Hepatology. 2016;63:691-3.
    PubMed     Text format    


  316. MEHAL WZ
    We are not in Kansas anymore: The unfamiliar landscape of NASH.
    Hepatology. 2016;63:682-4.
    PubMed     Text format    


  317. RINELLA ME
    Screening for nonalcoholic fatty liver disease in patients with atherosclerotic coronary disease?--In principle yes, in practice not yet.
    Hepatology. 2016;63:688-90.
    PubMed     Text format    


  318. DEVARBHAVI H, Raj S, Aradya VH, Rangegowda VT, et al
    Drug-induced liver injury associated with Stevens-Johnson syndrome/toxic epidermal necrolysis: Patient characteristics, causes, and outcome in 36 cases.
    Hepatology. 2016;63:993-9.
    PubMed     Text format     Abstract available


  319. WONG VW, Wong GL, Yeung JC, Fung CY, et al
    Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: A prospective cohort study.
    Hepatology. 2016;63:754-63.
    PubMed     Text format     Abstract available


  320. BERZIGOTTI A, Saran U, Dufour JF
    Physical activity and liver diseases.
    Hepatology. 2016;63:1026-40.
    PubMed     Text format     Abstract available


    February 2016
  321. YAO L, Wang C, Zhang X, Peng L, et al
    Hyperhomocysteinemia Activates the Aryl Hydrocarbon Receptor-CD36 Pathway to Promote Hepatic Steatosis in Mice.
    Hepatology. 2016 Feb 29. doi: 10.1002/hep.28518.
    PubMed     Text format     Abstract available


  322. CHEN YY, Jeffery HC, Hunter S, Bhogal R, et al
    Human intrahepatic tregs are functional, require IL-2 from effector cells for survival and are susceptible to fas ligand mediated apoptosis.
    Hepatology. 2016 Feb 29. doi: 10.1002/hep.28517.
    PubMed     Text format     Abstract available


  323. LEE TH, Rangan V, Khallafi H
    A Case of Sphenoid Sinus Metastasis in Hepatocellular Carcinoma.
    Hepatology. 2016 Feb 29. doi: 10.1002/hep.28516.
    PubMed     Text format    


  324. GONG Q, Hu Z, Zhang F, Cui A, et al
    Fibroblast Growth Factor 21 Improves Hepatic Insulin Sensitivity by Inhibiting Mammalian Target of Rapamycin Complex 1.
    Hepatology. 2016 Feb 29. doi: 10.1002/hep.28523.
    PubMed     Text format     Abstract available


  325. DE WAART DR, Naik J, Utsunomiya KS, Duijst S, et al
    ATP11C targets basolateral bile salt transporter proteins in mouse central hepatocytes.
    Hepatology. 2016 Feb 29. doi: 10.1002/hep.28522.
    PubMed     Text format     Abstract available


  326. TANIMIZU N, Kaneko K, Itoh T, Ichinohe N, et al
    Intrahepatic bile ducts are developed through formation of homogeneous continuous luminal network and its dynamic rearrangement.
    Hepatology. 2016 Feb 29. doi: 10.1002/hep.28521.
    PubMed     Text format     Abstract available


  327. LIU C, Liu L, Chen X, Cheng J, et al
    Sox9 Regulates Self-Renewal and Tumorigenicity by Promoting Symmetrical Cell Division of Cancer Stem Cells in Hepatocellular Carcinoma.
    Hepatology. 2016 Feb 22. doi: 10.1002/hep.28509.
    PubMed     Text format     Abstract available


  328. LI L, Che L, Tharp KM, Park HM, et al
    Differential Requirement for de novo Lipogenesis in Cholangiocarcinoma and Hepatocellular Carcinoma of Mice and Humans.
    Hepatology. 2016 Feb 22. doi: 10.1002/hep.28508.
    PubMed     Text format     Abstract available


  329. SIMON TG, Bonilla H, Yan P, Chung RT, et al
    Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and HCC, among patients with HCV Results from ERCHIVES.
    Hepatology. 2016 Feb 18. doi: 10.1002/hep.28506.
    PubMed     Text format     Abstract available


  330. D'AMICO G, Malizia G, Bosch J
    Beta-blockers in 2016: Still the safest and most useful drugs for portal hypertension?
    Hepatology. 2016 Feb 18. doi: 10.1002/hep.28502.
    PubMed     Text format    


  331. VILARINHO S, Sari S, Yilmaz G, Stiegler AL, et al
    Recurrent Recessive Mutation in DGUOK Causes Idiopathic Non-Cirrhotic Portal Hypertension.
    Hepatology. 2016 Feb 13. doi: 10.1002/hep.28499.
    PubMed     Text format     Abstract available


  332. CRAIG A, Villanueva A
    Liver Capsule: Molecular-based signatures in hepatocellular carcinoma.
    Hepatology. 2016 Feb 9. doi: 10.1002/hep.28489.
    PubMed     Text format    


  333. VILAR-GOMEZ E, Yasells-Garcia A, Martinez-Perez Y, Calzadilla-Bertot L, et al
    Development and validation of a noninvasive prediction model for nonalcoholic steatohepatitis resolution after lifestyle intervention.
    Hepatology. 2016 Feb 5. doi: 10.1002/hep.28484.
    PubMed     Text format     Abstract available


  334. TREBICKA J, Schierwagen R
    Hepatic mitochondrial dysfunction in non-alcoholic steatohepatitis: Read-out or reason?
    Hepatology. 2016 Feb 4. doi: 10.1002/hep.28482.
    PubMed     Text format    


  335. TAI WT, Chen YL, Chu PY, Chen LJ, et al
    Protein tyrosine phosphatase 1B dephosphorylates PITX1 and regulates p120RasGAP in hepatocellular carcinoma.
    Hepatology. 2016 Feb 3. doi: 10.1002/hep.28478.
    PubMed     Text format     Abstract available


  336. SAMI S, Mariella C, Valeria DC, Daniele A, et al
    A low-cost, user-friendly EEG recording system for the assessment of hepatic encephalopathy.
    Hepatology. 2016 Feb 2. doi: 10.1002/hep.28477.
    PubMed     Text format     Abstract available


  337. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2016;63:351-3.
    PubMed     Text format    


  338. PANG Q, Qu K, Liu C, Zhang JY, et al
    Sarcopenia and nonalcoholic fatty liver disease: New evidence for low vitamin D status contributing to the link.
    Hepatology. 2016;63:675.
    PubMed     Text format    


  339. HONG HC, Choi KM
    Reply.
    Hepatology. 2016;63:675-6.
    PubMed     Text format    


  340. SMAGRIS E, BasuRay S, Gromada J, Cohen JC, et al
    Reply.
    Hepatology. 2016;63:677.
    PubMed     Text format    


  341. ZHAO J, Lawless MW
    Resminostat: Opening the door to epigenetic treatments for liver cancer.
    Hepatology. 2016;63:668-9.
    PubMed     Text format    


  342. CUI J, Heba E, Hernandez C, Haufe W, et al
    Magnetic resonance elastography is superior to acoustic radiation force impulse for the Diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: A prospective study.
    Hepatology. 2016;63:453-61.
    PubMed     Text format     Abstract available


  343. HOLSTER IL, Tjwa ET, Moelker A, Wils A, et al
    Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + beta-blocker for prevention of variceal rebleeding.
    Hepatology. 2016;63:581-9.
    PubMed     Text format     Abstract available


  344. BJORNSSON ES, Hoofnagle JH
    Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports.
    Hepatology. 2016;63:590-603.
    PubMed     Text format     Abstract available


  345. REID LM, Sethupathy P
    The DNAJB1-PRKACA chimera: Candidate biomarker and therapeutic target for fibrolamellar carcinomas.
    Hepatology. 2016;63:662-4.
    PubMed     Text format    


    January 2016
  346. TAPPER EB
    Challenge accepted: Confronting readmissions for our patients with cirrhosis.
    Hepatology. 2016 Jan 25. doi: 10.1002/hep.28471.
    PubMed     Text format    


  347. SACK J, Garcia-Tsao G
    Variceal hemorrhage in a patient with HCV cirrhosis in whom liver synthetic function had normalized after viral elimination.
    Hepatology. 2016 Jan 25. doi: 10.1002/hep.28470.
    PubMed     Text format    


  348. KOH MY, Gagea M, Sargis T, Lemos R Jr, et al
    A new HIF-1alpha/RANTES driven pathway to hepatocellular carcinoma mediated by germline haploinsufficiency of SART1/HAF.
    Hepatology. 2016 Jan 22. doi: 10.1002/hep.28468.
    PubMed     Text format     Abstract available


  349. KWO P, Gitlin N, Nahass R, Bernstein D, et al
    Simeprevir Plus Sofosbuvir (12 and 8 Weeks) in HCV Genotype 1-Infected Patients Without Cirrhosis: OPTIMIST-1, a Phase 3, Randomized Study.
    Hepatology. 2016 Jan 22. doi: 10.1002/hep.28467.
    PubMed     Text format     Abstract available


  350. NORONHA FERREIRA C, Seijo S, Plessier A, Silva-Junior G, et al
    Natural history and management of esophagogastric varices in chronic non-cirrhotic non-tumoral portal vein thrombosis.
    Hepatology. 2016 Jan 22. doi: 10.1002/hep.28466.
    PubMed     Text format     Abstract available


  351. CALVISI DF
    Accomplices in Crime: The Diabolical Liaison between PTP1B and Ras in Hepatocellular Carcinoma.
    Hepatology. 2016 Jan 19. doi: 10.1002/hep.28462.
    PubMed     Text format    


  352. LENCIONI R, de Baere T, Soulen MC, Rilling WS, et al
    Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data.
    Hepatology. 2016 Jan 13. doi: 10.1002/hep.28453.
    PubMed     Text format     Abstract available


  353. TADDEI T
    Learning from the Melbourne experience: How reliable are cancer registry data for hepatocellular carcinoma?
    Hepatology. 2016 Jan 13. doi: 10.1002/hep.28452.
    PubMed     Text format    


  354. DESAI SS, Tung JC, Zhou VX, Grenert JP, et al
    Physiological Ranges of Matrix Rigidity Modulate Primary Mouse Hepatocyte Function In Part Through Hepatocyte Nuclear Factor 4 Alpha.
    Hepatology. 2016 Jan 11. doi: 10.1002/hep.28450.
    PubMed     Text format     Abstract available


  355. POORDAD F, Schiff ER, Vierling JM, Landis C, et al
    Daclatasvir With Sofosbuvir and Ribavirin for HCV Infection With Advanced Cirrhosis or Post-Liver Transplant Recurrence.
    Hepatology. 2016 Jan 11. doi: 10.1002/hep.28446.
    PubMed     Text format     Abstract available


  356. ZHOU SL, Hu ZQ, Zhou ZJ, Dai Z, et al
    miR-28-5p-IL-34-Macrophage Feedback Loop Modulates Hepatocellular Carcinoma Metastasis.
    Hepatology. 2016 Jan 11. doi: 10.1002/hep.28445.
    PubMed     Text format     Abstract available


  357. ZHAO L, Wong LL, Shi X, Ji J, et al
    Should hepatic dysplasia nodules and regenerative nodules be regarded as pre-malignant lesions and treated?
    Hepatology. 2016 Jan 11. doi: 10.1002/hep.28444.
    PubMed     Text format    


  358. SUNAMI Y, Ringelhan M, Kokai E, Lu M, et al
    Canonical NF-kappaB signaling in hepatocytes acts as a tumor-suppressor in HBV surface antigen-driven HCC by controlling the UPR.
    Hepatology. 2016 Jan 11. doi: 10.1002/hep.28435.
    PubMed     Text format     Abstract available



  359. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta-analysis.
    Hepatology. 2016;63:349.
    PubMed     Text format    



  360. Protein tyrosine phosphatase receptor S acts as a metastatic suppressor in hepatocellular carcinoma by control of epithermal growth factor receptor-induced epithelial-mesenchymal transition.
    Hepatology. 2016;63:349.
    PubMed     Text format    


  361. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2016;63:1-3.
    PubMed     Text format    


  362. LIM KC, Chow PK
    Reply.
    Hepatology. 2016;63:345.
    PubMed     Text format    


  363. DONG C, Peng S
    Contribution of nonignorable environmental factor to impairing liver disease mortality reduction target in China.
    Hepatology. 2016;63:347-8.
    PubMed     Text format    


  364. ZHANG Z, Gao B, Wang FS
    Reply.
    Hepatology. 2016;63:348.
    PubMed     Text format    


  365. GIANNINI EG, Stravitz RT, Caldwell SH
    Portal vein thrombosis and chronic liver disease progression: The closer you look the more you see.
    Hepatology. 2016;63:342-3.
    PubMed     Text format    


  366. DE MATTOS AZ, de Mattos AA
    Model for end-stage liver disease-based allocation system: On the right path, but not there yet.
    Hepatology. 2016;63:344.
    PubMed     Text format    


  367. ROSSO C, Mezzabotta L, Gaggini M, Salomone F, et al
    Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease.
    Hepatology. 2016;63:107-16.
    PubMed     Text format     Abstract available


  368. GOFFREDO M, Caprio S, Feldstein AE, D'Adamo E, et al
    Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: A multiethnic study.
    Hepatology. 2016;63:117-25.
    PubMed     Text format     Abstract available


  369. DUFOUR JF
    Time to Abandon NASH?
    Hepatology. 2016;63:9-10.
    PubMed     Text format    


  370. KOEHLER EM, Plompen EP, Schouten JN, Hansen BE, et al
    Presence of diabetes mellitus and steatosis is associated with liver stiffness in a general population: The Rotterdam study.
    Hepatology. 2016;63:138-47.
    PubMed     Text format     Abstract available


    December 2015
  371. WANG PX, Zhang XJ, Li H
    IRFs in hepatocytes pathophysiology.
    Hepatology. 2015 Dec 28. doi: 10.1002/hep.28433.
    PubMed     Text format    


  372. OH Y, Park O, Swierczewska M, Hamilton JP, et al
    Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells.
    Hepatology. 2015 Dec 28. doi: 10.1002/hep.28432.
    PubMed     Text format     Abstract available


  373. INTAGLIATA NM, Caldwell SH, Porte RJ, Lisman T, et al
    Prediction of bleeding in cirrhosis patients: Is the forecast any clearer?
    Hepatology. 2015 Dec 24. doi: 10.1002/hep.28426.
    PubMed     Text format    


  374. LAWITZ E, Matusow G, DeJesus E, Yoshida EM, et al
    Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A Phase 3 study (OPTIMIST-2).
    Hepatology. 2015 Dec 24. doi: 10.1002/hep.28422.
    PubMed     Text format     Abstract available


  375. TANOUE S, Kaplan DE
    CD14 regulatory Dendritic Cells in Hepatocellular Carcinoma and Cirrhotic patients.
    Hepatology. 2015 Dec 24. doi: 10.1002/hep.28419.
    PubMed     Text format    


  376. MAZZAFERRO V
    Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach.
    Hepatology. 2015 Dec 24. doi: 10.1002/hep.28420.
    PubMed     Text format    


  377. XIAO S, Chang RM, Yang MY, Lei X, et al
    ACTL6A predicts poor prognosis of Hepatocellular carcinoma and promotes metastasis and Epithelial-mesenchymal transition.
    Hepatology. 2015 Dec 23. doi: 10.1002/hep.28417.
    PubMed     Text format     Abstract available


  378. WANG MD, Wu H, Fu GB, Zhang HL, et al
    Acetyl-CoA carboxylase alpha promotion of glucose-mediated fatty acid synthesis enhances survival of hepatocellular carcinoma in mice and patients.
    Hepatology. 2015 Dec 23. doi: 10.1002/hep.28415.
    PubMed     Text format     Abstract available


  379. BAJAJ JS, Reddy KR, Tandon P, Wong F, et al
    The Three-Month Readmission Rate Remains Unacceptably High in a Large North American Cohort of Cirrhotic Patients.
    Hepatology. 2015 Dec 21. doi: 10.1002/hep.28414.
    PubMed     Text format     Abstract available


  380. IWAGAMI Y, Huang CK, Olsen MJ, Thomas JM, et al
    Aspartate beta-hydroxylase modulates cellular senescence via glycogen synthase kinase 3beta in hepatocellular carcinoma.
    Hepatology. 2015 Dec 19. doi: 10.1002/hep.28411.
    PubMed     Text format     Abstract available


  381. FURUTA K, Yoshida Y, Ogura S, Kurahashi T, et al
    Gab1 adaptor protein acts as a gatekeeper to balance hepatocyte death and proliferation during acetaminophen-induced liver injury in mice.
    Hepatology. 2015 Dec 17. doi: 10.1002/hep.28410.
    PubMed     Text format     Abstract available


  382. GUO Y, Wang J, Zhang L, Shen S, et al
    Theranostical nanosystem-mediated identification of an oncogene and highly effective therapy in hepatocellular carcinoma.
    Hepatology. 2015 Dec 17. doi: 10.1002/hep.28409.
    PubMed     Text format     Abstract available


  383. MEHTA N, Yao FY
    Nucleos(t)ide analogues to reduce the risk of Hepatitis B associated hepatocellular carcinoma: A can't miss proposition?
    Hepatology. 2015 Dec 17. doi: 10.1002/hep.28404.
    PubMed     Text format    


  384. ZHOU CC, Yang F, Yuan SX, Ma JZ, et al
    Systemic genome screening identified the outcome associated focal loss of long noncoding RNA PRAL in hepatocellular carcinoma.
    Hepatology. 2015 Dec 13. doi: 10.1002/hep.28393.
    PubMed     Text format     Abstract available


  385. OUYANG HY, Xu J, Luo J, Zou RH, et al
    MEP1A contributes to tumor progression and predicts poor clinical outcome in human hepatocellular carcinoma.
    Hepatology. 2015 Dec 13. doi: 10.1002/hep.28397.
    PubMed     Text format     Abstract available


  386. CAVALLIN M, Piano S, Romano A, Fasolato S, et al
    Terlipressin given by continuous i.v. infusion versus i.v. boluses in the treatment of hepatorenal syndrome: A randomized controlled study.
    Hepatology. 2015 Dec 13. doi: 10.1002/hep.28396.
    PubMed     Text format     Abstract available


  387. ZHANG Y, Liu Y, Duan J, Yan H, et al
    Hippocalcin-like 1 suppresses hepatocellular carcinoma progression by promoting p21 stabilization via activating ERK1/2-MAPK pathway.
    Hepatology. 2015 Dec 13. doi: 10.1002/hep.28395.
    PubMed     Text format     Abstract available


  388. LAN X, Yan J, Ren J, Zhong B, et al
    A Novel Long Non-coding RNA Lnc-HC Binds hnRNPA2B1 to Regulate Expressions of Cyp7a1 and Abca1 in Hepatocytic Cholesterol Metabolism.
    Hepatology. 2015 Dec 11. doi: 10.1002/hep.28391.
    PubMed     Text format     Abstract available


  389. TOSELLO-TRAMPONT AC, Krueger P, Narayanan S, Landes SG, et al
    NKp46 NK cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation.
    Hepatology. 2015 Dec 10. doi: 10.1002/hep.28389.
    PubMed     Text format     Abstract available


  390. CHEN DS, Liaw YF, Chen CJ, Wu JC, et al
    Differences in hepatitis viral etiology of hepatocellular carcinoma in Taiwan and China.
    Hepatology. 2015 Dec 10. doi: 10.1002/hep.28378.
    PubMed     Text format    


  391. LOCATELLI L, Cadamuro M, Spirli C, Fiorotto R, et al
    Macrophage recruitment by fibrocystin-defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis.
    Hepatology. 2015 Dec 8. doi: 10.1002/hep.28382.
    PubMed     Text format     Abstract available


  392. SEKI E
    HEDGEHOG signal in Hepatocytes mediates Macrophage Recruitment: A New Mechanism and Potential Therapeutic Target for Fatty Liver Disease.
    Hepatology. 2015 Dec 5. doi: 10.1002/hep.28381.
    PubMed     Text format    


  393. CHO NE, Bang BR, Gurung P, Li M, et al
    Retinoid Regulation of Antiviral Innate Immunity in Hepatocytes.
    Hepatology. 2015 Dec 5. doi: 10.1002/hep.28380.
    PubMed     Text format     Abstract available


  394. EKSTEEN B
    Predicting risk in Primary Biliary Cholangitis.
    Hepatology. 2015 Dec 5. doi: 10.1002/hep.28377.
    PubMed     Text format    



  395. 2015 Hepatology referees (volumes 61 and 62).
    Hepatology. 2015;62:1926-1930.
    PubMed     Text format    


  396. DUFOUR JF
    Hepatology highlights.
    Hepatology. 2015;62:1649-1651.
    PubMed     Text format    


    November 2015
  397. GUO H, Jing L, Cheng Y, Atsaves V, et al
    Downregulation of the Cyclin-Dependent Kinase Inhibitor p57 Is Mediated by Jab1/Csn5 in Hepatocarcinogenesis.
    Hepatology. 2015 Nov 25. doi: 10.1002/hep.28372.
    PubMed     Text format     Abstract available


  398. BLASI A, Hernandez-Gea V, Reverter JC, Garcia-Pagan JC, et al
    Quality of anticoagulation and outcome of bleeding in cirrhosis.
    Hepatology. 2015 Nov 25. doi: 10.1002/hep.28371.
    PubMed     Text format    


  399. QI X, De Stefano V, Guo X
    Quality of anticoagulation and outcome of bleeding in cirrhosis.
    Hepatology. 2015 Nov 25. doi: 10.1002/hep.28369.
    PubMed     Text format    


  400. BOSSEN L, Krag A, Vilstrup H, Watson H, et al
    Non-selective beta-blockers do not affect mortality in cirrhosis patients with ascites: Post hoc analysis of three RCTs with 1198 patients.
    Hepatology. 2015 Nov 24. doi: 10.1002/hep.28352.
    PubMed     Text format     Abstract available


  401. PISCAGLIA F, Svegliati-Baroni G, Barchetti A, Pecorelli A, et al
    Clinical patterns of hepatocellular carcinoma (hcc) in non alcoholic fatty liver disease (NAFLD): A multicenter prospective study.
    Hepatology. 2015 Nov 24. doi: 10.1002/hep.28368.
    PubMed     Text format     Abstract available


  402. JUNG KH, Zhang J, Zhou C, Shen H, et al
    Differentiation therapy for hepatocellular carcinoma: Multifaceted effects of miR-148a on tumor growth and phenotype and liver fibrosis.
    Hepatology. 2015 Nov 24. doi: 10.1002/hep.28367.
    PubMed     Text format     Abstract available


  403. REYES H
    Sulfated progesterone metabolites in the pathogenesis of intrahepatic cholestasis of pregnancy: Another loop in the ascending spiral of medical knowledge.
    Hepatology. 2015 Nov 24. doi: 10.1002/hep.28365.
    PubMed     Text format    


  404. FERRER-FABREGA J, Forner A, Liccioni A, Miquel R, et al
    Prospective validation of "ab initio" liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection.
    Hepatology. 2015 Nov 13. doi: 10.1002/hep.28339.
    PubMed     Text format     Abstract available


  405. GALUN E
    Liver inflammation and cancer: The role of tissue microenvironment in generating the tumor-promoting niche (TPN) in the development of hepatocellular carcinoma.
    Hepatology. 2015 Nov 13. doi: 10.1002/hep.28344.
    PubMed     Text format    


  406. DOSHI M, Pereira K, Carrion A, Martin P, et al
    Antegrade embolization of spontaneous splenorenal shunt for Post-TIPS refractory Hepatic Encephalopathy.
    Hepatology. 2015 Nov 13. doi: 10.1002/hep.28343.
    PubMed     Text format    


  407. JAESCHKE H, Du K
    Benzyl Alcohol: A novel treatment for acetaminophen overdose?
    Hepatology. 2015;62:1641-2.
    PubMed     Text format    


  408. ZUCKERBRAUN BS, Cai C, Billiar TR
    Reply: To PMID 24798499.
    Hepatology. 2015;62:1642.
    PubMed     Text format    


  409. YANG T, Zhang H, Lau WY, Shen F, et al
    Liver disease in China: A long way to go.
    Hepatology. 2015;62:1640.
    PubMed     Text format    


  410. ZHANG Z, Fan JG, Wang FS
    Reply: To PMID 25164003.
    Hepatology. 2015;62:1640-1.
    PubMed     Text format    


  411. BLECHACZ B, Mishra L
    Biopsy for liver cancer: How to balance research needs with evidence-based clinical practice.
    Hepatology. 2015;62:1645.
    PubMed     Text format    


  412. LEUNG DH, Khan M, Minard CG, Guffey D, et al
    Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease.
    Hepatology. 2015;62:1576-83.
    PubMed     Text format     Abstract available


  413. SIDDIQUE HR, Feldman DE, Chen CL, Punj V, et al
    NUMB phosphorylation destabilizes p53 and promotes self-renewal of tumor-initiating cells by a NANOG-dependent mechanism in liver cancer.
    Hepatology. 2015;62:1466-79.
    PubMed     Text format     Abstract available


  414. JO YS, Ryu D, Maida A, Wang X, et al
    Phosphorylation of the nuclear receptor corepressor 1 by protein kinase B switches its corepressor targets in the liver in mice.
    Hepatology. 2015;62:1606-18.
    PubMed     Text format     Abstract available


  415. HAGIWARA S, Nishida N, Park AM, Sakurai T, et al
    Impaired expression of ATP-binding cassette transporter G2 and liver damage in erythropoietic protoporphyria.
    Hepatology. 2015;62:1638-9.
    PubMed     Text format    


    October 2015
  416. YOKOMORI H, Yamazaki H, Oda M
    Freshwater clam extract supplement induced acute cholestasis.
    Hepatology. 2015 Oct 30. doi: 10.1002/hep.28320.
    PubMed     Text format    


  417. STINDT J, Kluge S, Droge C, Keitel V, et al
    Bile Salt Export Pump-reactive Antibodies Form a Polyclonal, Multi-inhibitory Response in Antibody-induced BSEP Deficiency.
    Hepatology. 2015 Oct 30. doi: 10.1002/hep.28311.
    PubMed     Text format     Abstract available


  418. HALAZUN KJ, Patzer RE, Rana AA, Samstein B, et al
    Reply: To PMID 24954365.
    Hepatology. 2015;62:1328-9.
    PubMed     Text format    


  419. YANG T, Lau WY, Huang B, Schwartz M, et al
    Transplantation for hepatocellular carcinoma: more haste, less speed?
    Hepatology. 2015;62:1327-8.
    PubMed     Text format    


  420. CLOSS EI
    Putative role of cationic amino acid transporter-3 in murine liver metabolism.
    Hepatology. 2015;62:1326-7.
    PubMed     Text format    


  421. GU Q, Cui Z
    Reply: To PMID 25130427.
    Hepatology. 2015;62:1327.
    PubMed     Text format    


  422. DALY AK, Day CP, Liu YL, Anstee QM, et al
    TM6SF2 as a genetic risk factor for fibrosis.
    Hepatology. 2015;62:1321.
    PubMed     Text format    


  423. SOOKOIAN S, Pirola CJ
    Reply: To PMID 25302781.
    Hepatology. 2015;62:1321-2.
    PubMed     Text format    


  424. VERMA M, Navarro V
    Patient-centered care: a new paradigm for chronic liver disease.
    Hepatology. 2015;62:988-90.
    PubMed     Text format    


  425. LEE YK, Jee BA, Kwon SM, Yoon YS, et al
    Identification of a mitochondrial defect gene signature reveals NUPR1 as a key regulator of liver cancer progression.
    Hepatology. 2015;62:1174-89.
    PubMed     Text format     Abstract available


  426. TOROK NJ
    Vascular adhesion protein 1 in nonalcoholic steatohepatitis: a novel biomarker?
    Hepatology. 2015;62:1313-5.
    PubMed     Text format    


  427. GUO W, Qiu Z, Wang Z, Wang Q, et al
    MiR-199a-5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer.
    Hepatology. 2015;62:1132-44.
    PubMed     Text format     Abstract available


  428. CHANG B, Xu MJ, Zhou Z, Cai Y, et al
    Short- or long-term high-fat diet feeding plus acute ethanol binge synergistically induce acute liver injury in mice: an important role for CXCL1.
    Hepatology. 2015;62:1070-85.
    PubMed     Text format     Abstract available


  429. PETTA S, Maida M, Macaluso FS, Di Marco V, et al
    The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease.
    Hepatology. 2015;62:1101-10.
    PubMed     Text format     Abstract available


  430. LAI M
    Is liver stiffness measurement to stage fibrosis in patients with nonalcoholic fatty liver disease ready for clinical use?
    Hepatology. 2015;62:997-8.
    PubMed     Text format    


    September 2015
  431. ZHOU M, Marc Learned R, Rossi SJ, DePaoli AM, et al
    Engineered FGF19 reduces liver injury and resolves sclerosing cholangitis in Mdr2-deficient mice.
    Hepatology. 2015 Sep 29. doi: 10.1002/hep.28257.
    PubMed     Text format     Abstract available


  432. PONSIOEN CY, Chapman RW, Chazouilleres O, Hirschfield GM, et al
    Surrogate endpoints for clinical trials in primary sclerosing cholangitis; review and results from an International PSC Study Group consensus process.
    Hepatology. 2015 Sep 29. doi: 10.1002/hep.28256.
    PubMed     Text format     Abstract available


  433. KIM SH, Saide K, Farrell J, Faulkner L, et al
    Characterization of amoxicillin- and clavulanic acid-specific T cells in patients with amoxicillin-clavulanate-induced liver injury.
    Hepatology. 2015;62:887-99.
    PubMed     Text format     Abstract available


  434. ZHOU JN, Zeng Q, Wang HY, Zhang B, et al
    MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4.
    Hepatology. 2015;62:801-15.
    PubMed     Text format     Abstract available


  435. REIG M, Bruix J
    Pattern of tumor progression in liver cancer: The missing partner in trial design.
    Hepatology. 2015;62:674-6.
    PubMed     Text format    


  436. VANWAGNER LB, Wilcox JE, Colangelo LA, Lloyd-Jones DM, et al
    Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study.
    Hepatology. 2015;62:773-83.
    PubMed     Text format     Abstract available


  437. BUTLER NS, Schmidt NW
    Erythropoietin-producing hepatocellular receptor B2 receptor tyrosine kinase: A novel regulator of infection- and inflammation-induced liver fibrosis.
    Hepatology. 2015;62:680-3.
    PubMed     Text format    


  438. NAULT JC, Rebouissou S, Zucman Rossi J
    NRF2/KEAP1 and Wnt/beta-catenin in the multistep process of liver carcinogenesis in humans and rats.
    Hepatology. 2015;62:677-9.
    PubMed     Text format    


  439. HOKI T, Miyanishi K, Tanaka S, Takada K, et al
    Increased duodenal iron absorption through up-regulation of divalent metal transporter 1 from enhancement of iron regulatory protein 1 activity in patients with nonalcoholic steatohepatitis.
    Hepatology. 2015;62:751-61.
    PubMed     Text format     Abstract available


  440. MARZANO C, Cazals-Hatem D, Rautou PE, Valla DC, et al
    The significance of nonobstructive sinusoidal dilatation of the liver: Impaired portal perfusion or inflammatory reaction syndrome.
    Hepatology. 2015;62:956-63.
    PubMed     Text format     Abstract available


    August 2015
  441. TRIVEDI PJ, Corpechot C, Pares A, Hirschfield GM, et al
    Risk Stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialists.
    Hepatology. 2015 Aug 20. doi: 10.1002/hep.28128.
    PubMed     Text format     Abstract available


    June 2015
  442. CHIANG JY
    Negative feedback regulation of bile acid metabolism: impact on liver metabolism and diseases.
    Hepatology. 2015 Jun 29. doi: 10.1002/hep.27964.
    PubMed     Text format    


  443. CARULLI L, Gabbi C, Bertolotti M
    Bile acids and non-alcoholic fatty liver disease: An intriguing relationship.
    Hepatology. 2015 Jun 29. doi: 10.1002/hep.27963.
    PubMed     Text format    


  444. BARBIER-TORRES L, Beraza N, Fernandez-Tussy P, Lopitz-Otsoa F, et al
    Histone Deacetylase 4 promotes cholestatic liver injury in the absence of Prohibitin-1.
    Hepatology. 2015 Jun 25. doi: 10.1002/hep.27959.
    PubMed     Text format     Abstract available


    May 2015
  445. KUMAR S
    Cholestatic Liver Injury secondary to Artemisinin.
    Hepatology. 2015 May 16. doi: 10.1002/hep.27900.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: